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Kurzfassung 
Im Protist Trypanosoma brucei liegen die meisten seiner kanonischen Organellen- 
das Flagellum, das Mitochondrium, der Golgi-Apparat- als einfache Kopie vor und 
daher wird er gerne zur Beantwortung von elementaren zellbiologischen Fragen he-
rangezogen. Bei Studien über die Replikation des Golgi-Apparats wurde eine neue 
Organelle des Zytoskeletts, genannt Bilobe, entdeckt. Kürzlich wurden zwei struktu-
relle Komponenten der Bilobe TbMORN1 und TbLRRP1 identifiziert. TbMORN1 
besteht aus einer höchst repetitiven Primärstruktur von 15 MORN-repeats, daher 
muss sich die Zielinformation zur Bilobe innerhalb dieser Wiederholungen befinden. 
Im Genom von T. brucei gibt es 17 weitere Leserahmen, welche MORN-repeat-
Proteine vorhersagen. Keines dieser Proteine ist experimentell charakterisiert. Unser 
primärer Ansatz war es daher, diese Proteine in prozyklischen Trypanosomen zu 
exprimieren und auf eine Lokalisierung auf der Bilobe hin zu untersuchen. Sieben 
Proteine lokalisierten zu dem Axoneme, eines zu dem PFR, zwei wurden am Basal 
body gefunden, drei waren im Zytosol vorhanden und eines möglicherweise auf dem 
Mitochondrium. 10 von 14 Proteinen wurden auf Strukturen des Zytoskeletts gefun-
den, was auf eine strukturelle Rolle der MORN-repeat-Proteine hinweist. Jedoch 
wurde keines auf der Bilobe entdeckt. Da die Zielinformation in der TbMORN1-
Sequenz vorhanden sein muss, führte ich parallel dazu Verkürzungsexperimente 
durch. Interessanterweise wurden die meisten verkürzten Proteine zusätzlich zur Bi-
lobe am basal body gefunden. Des Weiteren beobachtete ich bei C-terminal verkürz-
ten Proteinen TbMORN1(1-350) – TbMORN1(1-260), ein Muster von Lokalisierung 
und Misslokalisierung zur Bilobe. Meine Vermutung ist, dass diese ungewöhnliche 
Beobachtung durch hydrophobische Schlaufen, welche das Protein eventuell an die 
Plasmamembran binden können, zu erklären ist. Nach Auswertung aller Daten erga-
ben sich fünf wichtige Domänen. Die Aminosäuren 1-72 und 350-353 sind für eine 
Lokalisierung ausschließlich zur Bilobe notwendig, um eine starke, stabile Bindung 
herzustellen. Für die Bildung von sognannten „Spears“, parakistallinen Artefakten, 
wurden die Aminosäuren 343-350 als wichtig gefunden. Für das Bilobe-targeting 
sind die Aminosäuren 215-312 notwendig, wobei gleichzeitig ein targeting zum basal 
body stattfand. Für die Lokalisierung zum basal body war das letzte MORN-repeat 
ausreichend. Es ist möglich, dass das targeting durch eine Sequenz, welche nicht Teil 
der MORN-repeats ist, bewerkstelligt wurde. Aus meinen Daten ziehe ich den 
Schluss, dass das 3D-Motiv der entscheidende Faktor für das targeting von 
TbMORN1 an die Bilobe ist. 
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Abstract 
The protist Trypanosoma brucei posses most canonical eukaryotic organelles - flagel-
lum, mitochondrion, Golgi - in single copy and is therefore widely used to address 
basic cell biological questions. Previously a novel cytoskeletal organelle called the 
bilobe was serendipitously discovered during studies on Golgi replication. Recently 
two of its structural components TbMORN1 and TbLRRP1 were identified. 
TbMORN1 consists of a highly repetitive primary structure of 15 MORN - repeats. 
Therefore the targeting information to the bilobe must be somewhere in these re-
peats. In the T.brucei genome there are 17 other open reading frames predicted to 
encode MORN-repeat proteins which are all experimentally uncharacterized. The 
candidate approach was to express these proteins in procyclic Trypanosomes and 
screen them for localization redolent of the bilobe. 7 proteins localized to the 
axoneme, 1 to the PFR, 2 were found at the basal body, 3 were present in the cytosol 
and one might be mitochondrial. 10/14 proteins where found on cytoskeletal struc-
tures which hints at a structural role of MORN-repeat proteins. However none were 
found at the bilobe. Since TbMORN1 must have the targeting information some-
where in its sequence I in parallel generated truncation constructs to gain information 
on which MORN-repeats are essential and which are dispensable for bilobe localiza-
tion. Interestingly most of the truncated proteins were additionally found at the basal 
body in intact cells which suggests that tagged proteins might traffic to the bilobe 
through the basal body. I further observed a strange pattern of localization and mis-
localization to the bilobe in C-terminal truncations, TbMORN1(1-350)- 
TbMORN1(1-260). I suggest that this unusual observation could be explained by 
hydrophobic loops which might bind the protein to the plasma membrane. Combin-
ing data from all truncations, I found that 5 domains are important. Amino acids 1-72 
and 350-353 are required for targeting exclusively to the bilobe and forming a strong, 
stable association. The domain 343-350 was found important for the formation of 
spears, artefactual paracrystaline structures. Further, amino acids 215-312 are neces-
sary for bilobe targeting with impaired targeting to the basal body. For targeting to 
the basal body the last MORN-repeat was sufficient. It is possible that the target-
ing is achieved through a sequence that is not part of the MORN-repeat con-
sensus sequence. Concluding from our data I rather suggest that a 3D motif is 
the crucial factor for targeting TbMORN1. 
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1  Introduction 
1.1 Trypanosoma brucei 
The protist Trypanosoma brucei is a simple eukaryote. As an obligate parasite it is 
the causative agent of sleeping sickness in humans and nagana in animals. These 
diseases severely affect social and economic development in sub-Saharan Africa. 
There are two subspecies Trypanosoma brucei gambiense and Trypanosoma brucei 
rhodesiense which are infective to human (WHO Media Centre, 
http://www.who.int/mediacentre/factsheets/fs259/en/). The incidence may approach 
300 000 to 500 000 cases per year and the disease is invariably fatal if untreated 
(Berriman et al., 2005). Vaccines or adequate drugs for effective treatment of this 
disease are currently not available (Simarro et al., 2008). During its complex life cy-
cle Trypanosomes migrate between a mammalian host and an insect vector, the tsetse 
fly. The main developmental form found in the insect is the gut stage procyclic form; 
the main type in the human host is the bloodstream form. The cells of both forms are 
covered in a glycoprotein surface coat. The procyclic form surface coat consists of 
acidic repeat proteins (procyclins) whereas the bloodstream form is mainly covered 
by a single isoform of variant surface glycoprotein (VSG) (McConville and Fergu-
son, 1993; Ferguson, 1999). Trypanosomes evade the host adaptive immune response 
by changing the composition of this VSG coat. This glycoprotein is encoded in a 
polycistronic transcribed telomeric expression site and there are also many silent 
copies found (Horn et al., 2010). Trypanosoma brucei is not only a devastating 
pathogen but has also become an interesting model organism for basic science con-
tributing to better understanding of common cellular mechanisms. Due to the fact 
that Trypanosomes are simpler than mammalian cells but posses the canonical eu-
karyotic organelles they are increasingly used as model systems for eukaryotic cell 
biology. RNA editing and glycosylphosphatidylinositol anchoring were first discov-
ered in Trypanosomes (Benne et al., 1986; Ferguson et al., 1985). Furthermore the 
complete Trypanosome genome has been sequenced and the availability of RNA 
interference make them suitable for application of reverse genetics (Berriman et al., 
2005). 
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1.2 Trypanosome cell structure 
T. brucei cells contain a single nucleus, a single flagellum, a basal body and its im-
mature form (the pro-basal body), a single Golgi, and a single elongated mitochon-
drion containing the mitochondrial genome (Hammarton et al, 2007a) (Fig.1.2.1). 
The mitochondrial genome is also unique as it is condensed into a disc-like structure 
termed the kinetoplast (Hammarton et al, 2007a). The kinetoplast DNA network is 
composed of several thousand mini-circles that are interlocked. Also intertwined are 
a few dozen maxi-circles which code for gene products such as rRNA and subunits 
of the respiratory complexes. Mini-circles encode for guide RNAs that edit maxi-
circle transcripts (Klingbeil et al., 2004). RNA editing describes the process in which 
precursor mRNA sequences are often exchanged by the insertion or less frequently 
by the deletion of uridine nucleotides (Stuart et al., 2005). 
 
Fig. 1.2.1 Thin-section electron micrograph through a procyclic Trypanosome.  
 N: nucleus; A: axoneme; PFR: paraflagellar rod; F: flagellum; G: Golgi; FP: flagel-
lar pocket; FPC: flagellar pocket collar; BB: basal body; PBB: pro-basal body; K: 
kinetoplast. The posterior and anterior ends of the cell are indicated. Taken from Ye-
linek et al., 2009 
The typical vermiform cell morphology of Trypanosomes is generated by an internal 
cytoskeleton consisting of a cage-like arrangement of more than 100 subpellicular 
microtubules (MTs) (Sherwin et al., 1989). A precise inter-microtubular distance of 
18-22nm is maintained by cross-bridges that link the MTs to each other and to the 
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inner face of the plasma membrane. The plus ends of the subpellicular MTs termi-
nate at the posterior end of the cell (Fig. 1.2.1). 
The direction of cell movement is determined by the flagellum beating which occurs 
from tip to base (Hammarton et al., 2007a). The flagellum is a highly complex or-
ganelle composed of several different structures. Its main component, the axoneme, 
is formed by a „9+2‟ arrangement of MTs which is a highly conserved structure 
among all flagella and cilia in eukaryotes (Ginger et al., 2008). Physically attached to 
the axoneme is a second large cytoskeletal structure, the paraflagellar rod (PFR). 
Two main protein components PFR1 and PFR2 (previously PFRC and PFRA) have 
been identified and are encoded by repeated gene arrays in the T. brucei genome 
(Gadelha et al., 2004). 
The flagellum is nucleated at the basal body, a structure which abuts an invagination 
of the plasma membrane termed the flagellar pocket (FP). The FP is a plasma mem-
brane sub-domain which is the sole site of endo- and exocytosis (Absalon et al., 
2008). The FP is thus the site of trafficking and recycling of glycosylphosphatidy-
linositol - anchored surface proteins and the VSG antigen, playing an important func-
tion in the Trypanosome‟s defence against the host immune system (Allen et al., 
2003). The Trypanosome flagellum is attached to the cell body through the flagellum 
attachment zone (FAZ). The FAZ is composed of a microtubular quartet with associ-
ated membrane and a specific FAZ filament structure (Lacombe et al., 2008). During 
the cell cycle an additional structure, the flagellar connector (FC), is observed in pro-
cyclic Trypanosomes. The FC ensures that the new elongating flagellum migrates 
along the old flagellum and is placed in a parallel orientation. On top of its structural 
and mobility functions the flagellum is essential for cell division and further pos-
sesses a highly active intra-flagellar transport system (IFT) (Hammarton et al, 
2007a). IFT is the bi-directional transport of flagellum components by two IFT com-
plexes A and B. The anterograde transport of IFT particles to the flagellar tip is per-
formed by a heterotrimeric kinesin-2 motor protein. The transport back to the cell 
body, called retrograde transport, is carried out by dynein-1b motors (Pederson and 
Rosenbaum, 2008; Pigino et al., 2009). 
The main microtubular organizing center (MTOC) of T. brucei is the basal body sub-
tending the flagellar axoneme (Lacombe et al., 2008). The microtubular quartet is 
nucleated between the basal body and the pro-basal body (Tayler and Godfrey, 1969). 
This microtubular quartet has the opposite polarity to the corset microtubules. The 
structure extends along and around the FP membrane in a left-handed helical manner 
inserting into the subpellicular array of microtubules (Lacombe et al., 2008). Two 
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boundaries define the flagellar pocket, a structure termed the collar and the neck re-
gion (Henley et al., 1978; Sherwin and Gull, 1989). The flagellar pocket collar is 
visible as an electron-dense structure by electron microscopy (Fig.1.2.1) Recently the 
first component from the flagellar pocket collar was identified, a cytoskeletal protein 
termed BILBO1 (Bonhivers et al., 2008). The neck region is a cylindrical region of 
the plasma membrane and defines the transition between the internal membrane and 
the external plasma membrane of the cell surface (Lacombe et al., 2008). 
The pro-basal body forms a new flagellum in the proximate cell cycle. Both the mor-
phology and function of basal bodies are analogous to the centrioles of mammalian 
cells (Vaughan et al., 2008). 
 
1.3 Cell division of procyclic Trypanosomes  
At the start of the Trypanosome cell cycle the cell contains a single kinetoplast and a 
single nucleus, this stage is also referred to a 1K1N cell. Cell division in Trypano-
somes is unusual as two distinct S-phases need to be co-coordinated - one for the 
single mitochondrial DNA and one for nuclear DNA. This process starts with the S-
phase of the mitochondrial DNA (Vaughan et al., 2008). At the G1-S transition the 
pro-basal body matures, elongates and invades the FP. Then the new flagellum starts 
to grow. The new basal body performs a rotation in anti-clockwise direction around 
the old flagellum while its new axoneme is associated with the pre-existing FP. This 
rotation results in division of the FP (Lacomble et al., 2010). The new flagellum 
stays connected to the old flagellum through the FC which migrates simultaneously 
with the out-growing flagellum (Fig. 1.3.1 B). In T. brucei growth of the new flagel-
lum is crucial for cell division where it ensures transmission of cell polarity. Interest-
ingly the FC stops at a precise length along the old flagellum and this stop coincides 
with basal body and kinetoplast segregation (Vaughan et al., 2008). Golgi duplication 
occurs via the formation of a new Golgi next to a new endoplasmic reticulum export 
site (ERES) (He et al., 2004). Recently it was shown that the entire ERES : Golgi 
complex is associated with the Trypanosome cytoskeleton, likely via the FAZ (Se-
vova et al., 2009). Furthermore, in bloodstream form cells it was proposed that single 
ER : Golgi pairs are present near the nucleus while in cells with two pairs the second 
is placed near the FP suggesting that it forms the new Golgi (Sevova et al., 2009). 
Following Golgi duplication the new FAZ is assembled. This 1K1N cell duplicates 
and segregates its kinetoplast forming a 2K1N cell (de Graffenried et al., 2008).  
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Fig. 1.3.1 Illustration of the cell cycle of procyclic T. brucei. 
(A) A 1K1N cell contains one kinetoplast, one nucleus and a single attached flagel-
lum. (B) The pro-basal body matures and a new flagellum extends which is con-
nected to the old flagellum by the flagella connector. (C) The flagellar connector 
stops at a precise distance. This coincides with basal body and kinetoplast segrega-
tion. Then mitosis occurs forming a 2K2N cell. (D) Cytokinesis proceeds from the 
anterior end to the posterior by flagellar beating. Taken from Vaughan et al., 2008. 
Nuclear replication takes considerably longer than mitochondrial S-phase. Mitosis 
leads to one of the two nuclei positioned between the two kinetoplasts ensuring that 
cytokinesis will yield two daughter cells (Fig. 1.3.1 C). This stage of cell division is 
referred to as a 2K2N cell. Interestingly, the mitosis occurs without chromosome 
condensation or nuclear breakdown (Hammarton et al., 2007b). Cleavage furrow 
ingression is performed along the cell body from the anterior to posterior end be-
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tween the old and the new flagellum (Fig. 1.3.1 D) (Vaughan et al., 2008). Finally the 
two daughter cells remain attached to each other for some time before final abscis-
sion is achieved through flagellar beating. 
 
1.4 Discovery of the bilobe 
The work of the Warren group concerns the eukaryotic cell cycle, and specifically the 
mechanism of Golgi replication. In contrast to mammalian cells Trypanosomes con-
tain a single Golgi and were used as a model system. In mammalian cells the Golgi is 
juxtaposed the main MTOC, the centrosome. In Trypanosomes however the main 
cytoplasmic MTOC is the basal body which is found at the wrong side of the FP rela-
tive to the Golgi (Fig.1.4.1). In addition to the basal body there needs to be an MTOC 
component inside the nucleus since Trypanosomes perform a closed mitosis. The 
question now is if there is an analogous structure to the centrosome which ensures 
Golgi segregation.  
Ca
2+
 binding proteins, called centrins, are conserved components of MTOCs. The 
monoclonal antibody 20H5, originally raised against centrin from Chlamydomona 
reinhardtii, labels centrins in a wide range of organisms (Salisbury et al., 1988). In T. 
brucei it was serendipitously found that this pan-centrin antibody stains a bilobe 
structure in addition to the basal body (Fig. 1.4.1 A) (He et al., 2005). As a totally 
novel structure, the group has since then been trying to determine its form, function, 
and biogenesis. Key to answering these questions is the identification of bilobe – 
resident proteins. 
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Fig. 1.4.1 Gallery of images through the cell cycle of procyclic Trypanosomes. 
GRASP: Golgi reassembly stacking protein; 20H5: pan-centrin antibody; open ar-
rowheads: basal bodies; solid arrowheads: bilobed structure; arrows: Golgi. (A and 
B) Pan-centrin antibodies label the basal body and additional bilobed structure next 
to the Golgi. (C and D) The basal body duplicates followed by kinetoplast duplica-
tion and segregation (E). (F) 2K2N cell ready for cytokinesis. Taken from He et al., 
2005. 
 
1.5 Proteins at the bilobe 
1.5.1 TbCentrin2 
In T.brucei there are 5 known centrin isoforms. TbCentrin2, along with TbCentrin1 
is one of two isoforms detected by 20H5 antibody (He et al., 2005). TbCentrin2 lo-
calizes to the flagellum, the basal body and the bilobe. Depletion of TbCentrin2 by 
RNA interference (RNAi) causes an inhibition of basal body division. Since TbCen-
trin2 is also found at the basal body this restricts its usefulness as a marker for the 
bilobe. This also makes it impossible to determine bilobe function because depletion 
experiments will cause loss from the basal body as well as the bilobe. Therefore, any 
observed effects could be caused by basal body malfunction. Better understanding of 
the form and function of the bilobe needs identification of more specific components. 
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1.5.2 TbCentrin4 
TbCentrin4 (previously named TbCen1) localizes to the basal body and to the bilobe 
structure. This was confirmed by fluorescent protein and epitope tags (Selvapandiyan 
et al., 2007). Due to the lack of a ten amino acid long epitope TbCen4 is not recog-
nized by 20H5 antibodies. Upon depletion of TbCentrin4 by RNAi (>48 hours) there 
was disruption of cell cycle progression and an accumulation of multinucleated cells 
and zoids (cells without a nucleus), was observed. This phenotype was similar to that 
found in TbCentrin2-depleted cells except for the abundance of zoids (He et al., 
2005). The observation of zoids and 1K2N cells suggests that these cells were pro-
duced as siblings by incorrect placement of the cleavage furrow and unequal abscis-
sion. However all other organelles examined - the basal bodies, kinetoplast, Golgi, 
lysosomes, flagella and the FAZ - appeared to replicate properly and were found in 
both cell types. Thus, cell division seems to occur before full segregation of the du-
plicated nuclei in TbCentrin4 RNAi cells (Shi et al., 2008). Given that both TbCen-
trin2 and TbCentrin4 have multiple localizations this makes it different to determine 
exact function of the bilobe. 
1.5.3 TbPLK  
Polo-like kinases (PLK) are a family of eukaryotic mitotic kinases. T.brucei contains 
a single PLK homologue that has been linked to cytokinesis (Kumar and Wang, 
2006). In Immunofluorescence microscopy TbPLK partially colocalized with the 
bilobed structure. Interestingly, at early times in the cell cycle TbPLK was concen-
trated at the basal bodies and the posterior lobe of the bilobe. After basal body repli-
cation the signal from TbPLK increased on the duplicating bilobe. Once bilobe du-
plication was completed the TbPLK signal from the bilobe was lost and the signal 
appeared at the growing tip of the FAZ. Upon TbPLK depletion by RNAi, cells be-
gan to accumulate in the 2K2N state. After 20 hours cells increased in size and had 
multiple detached flagella. 24hours post induction a large number of multinucleated 
cells and zoids were observed. Furthermore a clear defect in bilobe morphology and 
number was seen. The observation that fewer 1K1N cells had two bilobes suggested 
a delay in bilobe biogenesis. At the same time the number of cells with malformed 
bilobes and five or more Golgi increased. Thus TbPLK localization and its depletion 
effects suggest that the kinase plays an important role in bilobe duplication (de Graf-
fenried et al., 2008).  
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1.5.4 TbLRRP1 
The bilobe protein TbLRRP1 was recently identified through comparative proteomic 
analysis (Zhou et al., 2010). This protein contains several leucine rich repeats in its 
N-terminal region and a coiled coil motif at the C-terminus. In immunofluorescence 
microscopy images TbLRRP1 was present on the bilobe together with TbCentrin4 
through the entire cell cycle. The TbLRRP1 labelled bilobe was adjacent to the flag-
ellar pocket collar on the posterior side and the FAZ on the anterior side. Upon de-
pletion of TbLRRP1 by RNAi, cell duplication first slowed down and then stopped 
72 hours after induction. Accumulation of 1K2N cells was observed which might be 
due to a lack of kinetoplast segregation. Clustering of duplicated basal bodies and 
flagella also suggested a failure in segregation of these organelles. Additionally mo-
tility defects were observed. New flagella appeared to be shorter than those in control 
cells although no structural defects in the axoneme or PFR could be observed by 
electron microscopy. Duplication of the Golgi, flagellar pocket collar and FAZ were 
all inhibited. In more than 70% of 1K2N cells a single bilobe as well as a single FAZ 
was observed. Furthermore the new FAZ was often shorter than the old, more ante-
rior one. The lack of the new FAZ might also be an explanation for the inhibited seg-
regation of the basal body and the kinetoplast. Together these data suggest a role of 
the bilobe in FAZ formation (Zhou et al., 2010). 
 
1.6 Identification of TbMORN1 
Prior to discovery of TbLRRP1, the only protein known to localize exclusively to the 
bilobe was TbMORN1, a MORN-repeat protein (Morriswood et al., 2009). MORN-
repeats are 23 amino acid long protein motifs with a general consensus sequence of 
YXGX(W/F)X6GXGX6GX2 (Im et al., 2007). This bilobe constituent protein was 
identified by using a comparative proteomic strategy. Using detergent and high salt 
the Trypanosome flagella also co-purifies with the basal body and the bilobe struc-
ture which suggests a tight association with the flagellar cytoskeleton. The flagellum 
proteome must therefore contain bilobe proteins in addition to axoneme, PFR, and 
basal body ones. From this flagellum proteome the proteomes of Chlamydomonas 
reinhardtii and Tetrahymena thermophila flagella/cilia were subtracted (Broadhead et 
al., 2006). Subtraction resulted a shortlist of 180 putative bilobe/basal body proteins 
from which 12 proteins were picked randomly and screened for localization by im-
munofluorescence using a yellow fluorescent protein (YFP) tag. One protein, 
Tb927.6.4670, had a promising distribution redolent of the bilobe structure. Further 
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experiments confirmed the localization of Tb927.6.4670 at the bilobe but not the 
basal body or flagellum (Fig. 1.6.1). Tb927.6.4670, later termed TbMORN1, is a 358 
amino acid, approximately 40 kDa protein with 15 tandem MORN-repeats (Morris-
wood et al., 2009). The YFP-tagged protein, as well as an epitope tagged version and 
antibodies against the endogenous protein, showed a range of hooked and pronged 
morphologies in immunofluorescence microscopy analysis. It is not clear if these 
morphologies represent the bilobe viewed from different angles or show its replica-
tion cycle. Besides its different morphologies the overlap of TbMORN1 with 20H5 
labelling and TbCentrin4 is extensive but not complete. TbCentrin4 was present in 
the same cell volume but doesn‟t colocalize with TbMORN1 and is also present at 
the basal bodies. It is unclear if the bilobe is composed of several sub domains and if 
TbCentrin4 and TbMORN1 localize preferentially to different parts of these sub do-
mains. Furthermore in the YFP-TbMORN1 expressing cells intensely bright “spear” 
structures were additionally observed in 35% of cells. By transmission electron mi-
croscopy these structures were found to be paracrystalline artefacts which nonethe-
less hints at a high capacity for self-organization (Morriswood et al., 2009). 
 
Fig. 1.6.1 Detergent-extracted cytoskeletons of procyclic cells fixed with para-
formaldehyde (PFA) and labelled with anti-TbMORN1 and the pan-centrin 
antibody 20H5. 
Αnti-TbMORN1 and 20H5 overlap at the bilobe. Arrows: bilobed structure; arrow-
heads: basal body. Single section of 0.1µm. Scale bar 1µm. Taken from Morriswood 
et al., 2009. 
Depletion of TbMORN1 by RNAi experiments produced a mild growth defect in 
procyclic Trypanosomes. Surprisingly no alteration of the bilobe labelling with 20H5 
could be observed. All 2K2N cells displayed proper duplicated bilobes. One possible 
explanation could be that because 20% of wild-type TbMORN1 was still present 
upon induction in RNAi cells this is sufficient for bilobe formation. In bloodstream 
Trypanosomes in contrast, the depletion of TbMORN1 was lethal 24 hours post-
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induction. This implies that TbMORN1 is an essential gene in the bloodstream form 
(Morriswood et al., 2009). 
In other eukaryotes the MORN1 protein is highly conserved among apicomplexan 
parasites, one of these homologues is TgMORN1 in Toxoplasma gondii (Ferguson et 
al., 2008). TgMORN1 is composed of 15 MORN-repeats and a short linker sequence 
of 5 amino acids between MORN repeat 6 and 7 (Gubbels et al., 2006). In Toxop-
lasma gondii MORN1 localized to the centrocone, a structure within the nuclear 
envelope, and to the basal and apical ends of the parasitic cell. TgMORN1 is the ma-
jor component of the basal complex, a cytoskeletal structure at the posterior end of 
the cell (Hu et al., 2006; Lorestani et al., 2010). Toxoplasma divides through a highly 
specific mechanism called endodyogeny where two parasites are formed within the 
mother parasite. TgMORN1 is further involved in the Toxoplasma gondii replication 
cycle where it forms a ring structure near the duplicated centrioles and moves along 
the daughter cell and has contraction capacity. Interestingly, TgMORN1 null mutants 
show a bizarre phenotype where double-headed parasites accumulate. These Janus-
headed parasites form the apical complexes but fail to assemble the basal complex. A 
lack of TgMORN1 leads to incomplete cytokinesis, and more precisely to incomplete 
abscission. Budding still takes place which can lead to up to 16-headed parasites. 
Together these data suggests that TgMORN1 is essential for functional basal com-
plex formation. Furthermore the mutants fail to constrict and divide the apicoplast, 
an organelle found in most apicomplexa (Lorestani et al., 2010). 
 
1.7 MORN-repeat proteins  
MORN-repeat proteins were first observed in transmembrane junctional complexes 
of mammalian skeletal muscle cells where they link the sarcoplasmic reticulum to 
the plasma membrane (Takeshima et al., 2000). MORN-repeats are thought to be 
employed as plasma membrane localization devices and are found in conjunction 
with various enzymatic and protein-protein interaction domains, the best character-
ized being a phosphatidylinositol phosphate kinase (PIPK) in plants (Ma et al., 
2006). 
 
This plant PIPK contains a short N-terminal sequence followed by a MORN-repeat 
domain with 8 repeats and a C-terminal catalytic domain separated by a short linker 
sequence. Recent findings proposed that the MORN domain regulated plasma mem-
brane localization and phosphatic acid-inducible activation. However deletion of the 
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N-terminal region reduced PIPK1 activity 40% compared to the full-length enzyme. 
Surprisingly the loss of the MORN repeats had no significant effect. The mutant 
lacking the 8 MORN-repeats showed no difference in activity (Mikami et al., 2010). 
These findings raise the question of the function of MORN-repeats. In T.brucei there 
are additional to TbMORN1 17 other open reading frames (ORFs) predicted to en-
code MORN-repeat proteins which are all experimentally uncharacterized. 
 
1.8 Project outline & Aims 
Previously, a novel cytoskeletal structure called the bilobe was identified in T.brucei 
(He et al., 2005) The function of this organelle remains unclear. So far only two pro-
teins are known to localize exclusively to the bilobe, TbMORN1 (Morriswood et al., 
2009) and TbLRRP1 (Zhou et al., 2010). TbCentrin4 doesn‟t completely overlap 
with TbMORN1 and is also present at the basal bodies (Shi et al., 2008). TbPLK was 
transiently present at the bilobe during cell division (de Graffenried et al., 2008). 
 
TbMORN1 consists of a highly repetitive primary structure of 15 MORN-repeats. 
Therefore the targeting information to the bilobe must be somewhere in these 
MORN-repeats. The aim of this project was to identify the targeting sequence of 
TbMORN1 and define which of these MORN-repeats are essential and which are 
dispensable for proper localization. This would thereby provide more information 
about MORN-repeats and their possible functions. 
Given that TbMORN1 targets to the bilobe the targeting must be mediated by its 
repeats. Since all other 17 predicted MORN-repeats containing proteins are unchar-
acterized the candidate approach was to express these proteins in procyclic Trypano-
somes and screen them for possible bilobe localization. 
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2 Materials and Methods  
Applied methods are grouped into five categories: (2.1) Gene cloning, (2.2) Cell cul-
ture and Transfection, (2.3) Immunofluorescence, (2.4) Protein methods and (2.5) 
Bioinformatics. Gene cloning covers all steps from the purification of Trypanosome 
genomic DNA to generation of expression constructs. Cell culture and Transfection 
describes methods as transient transfection and generation of stable cell lines. The 
section Immunofluorescence contains protocols for cell fixation and immunofluores-
cence microscopy. Protein methods include commonly used applications such as 
whole cell lysate preparation, biochemical fractionation and Western blot analysis. 
Bioinformatic applications are included in the last section of this chapter. 
During the project I followed two series of experiments- screening of the MORN-
repeat family to define subcellular localization, and analyzing truncations of 
TbMORN1 to determine targeting. Therefore the strategy described in Fig. 2.1 was 
performed. First the ORF was cloned as described in the section general cloning 
strategy. The amplified ORF was ligated into the pxS2-YFP expression vector creat-
ing N- or C-terminally YFP tagged constructs. Then procyclic T.brucei 29.13 (for 
screening proteins 1-8) or T.brucei 427 (for all other experiments) cells were tran-
siently transfected and analyzed by immunofluorescence microscopy to determine 
subcellular localizations. Samples were fixed with either PFA or methanol (MeOH) 
or detergent-extracted (Xtr) and fixed with PFA. Anti-GFP antibodies were used to 
enhance the YFP signal. For distinct localization further tests using cytoskeletal and 
organelle markers were performed. In order to confirm expression of YFP fusion 
proteins I performed Western blot analysis using antibodies against GFP. These anti-
bodies recognize YFP tags as the primary sequence difference between GFP and 
YFP is comparatively slight. Additionally I either analyzed whole cell lysates for the 
MORN-family, or performed biochemical fractionation of the TbMORN1 truncation 
proteins. To determine hydrophobicity I analyzed truncated TbMORN1 proteins on a 
Kyte-Doolittle hydrophobicity plot. 
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Fig  2.1 Flow chart outlining the performed strategy 
 
2.1 Gene cloning 
2.1.1 General strategy 
At the beginning of the project the cloning strategy as outlined in Fig. 2.1.1 was per-
formed. For the MORN-family the amplification of genes of interest was achieved by 
polymerase chain reaction (PCR) using primers annealing to the beginning and end 
of the selected gene locus on genomic DNA. The TbMORN1 truncation constructs 
were obtained by subcloning from a parental construct, pGEX-TbMORN1. To gen-
erate truncated versions primers binding to indicated positions were used for PCR. 
These primers additionally introduced sites for restriction enzymes. During the pro-
ject I used the following enzymes: BamHI, Bgl2, Bcl1, EcoRI, HindIII, NheI either 
cutting upstream or downstream of the YFP construct (Fig.2.1.2). Blunt-ended PCR 
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products were separated by gel electrophoresesis and desired product bands were 
purified by gel extraction. Digestion with the appropriate restriction enzymes enabled 
ligation into the pxS2-YFP expression vector. The MORN-family constructs were 
either N- or C-terminally YFP-tagged depending on which restriction sites were 
available. TbMORN1 truncation constructs were all N-terminally YFP tagged. There 
is some evidence that a C –terminal tag prevents proper targeting of TbMORN1 (B. 
Morriswood, unpublished results). The first choice would therefore be to use BamH1 
and EcoR1 but unfortunately TbMORN1 has internal restriction sites for both en-
zymes. These enzymes were therefore used only for short truncation constructs lack-
ing the appropriate sites. For full-length and large constructs we applied Bgl2 which 
leaves the same overhang as BamH1. For Bgl2 digested PCR fragments, BamH1 and 
calf intestinal phosphatase (CIP) - treated vector was used. The ligation products 
were then used to transform bacteria and individual colonies were screened for the 
presence of the gene of interest by colony PCR. Putative positive colonies were fur-
ther screened by restriction digestion of purified plasmid minipreps. The isolated 
minipreps were then sequenced to check if any mutations had been acquired. Due to 
the fact that Trypanosomes need a high amount of DNA for successful transfection I 
carried out maxipreps of the expression constructs. 
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Fig. 2.1.1 Gene cloning. 
Flow chart showing performed cloning strategy. 
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Fig. 2.1.2 Parts of the pxS2-YFP expression vector showing appropriate sites for 
restriction enzymes. 
Arrows indicate primer annealing sites for insert sequencing. 
 
2.1.2 Purification of total DNA 
DNA purification was carried out using QIAgen DNeasy Blood & Tissue kit accord-
ing to the manufacturer's instructions with the following adaptations. In the first step 
in the protocol, 1x10
7
 cells were utilized and centrifuged for 1 min at 6000rpm. 
Given that Trypanosomes posses a microtubular corset I used 40µl proteinase K and 
increased the incubation time to 40 min in order to destroy the tight cytoskeletal 
structure of these cells. Finally DNA was eluted by applying 100µl of Buffer EB di-
rectly onto the membrane and centrifugation for 1 min at 8000rpm after 1 min of 
incubation at room temperature. This process was performed twice and eluted DNA 
was aliquoted and stored at -20°C. 
2.1.3 Amplification of DNA by PCR 
For amplification of DNA by PCR my first choice was to use Vent DNA polymerase 
which has a high fidelity deriving from an integral 3‟- 5‟ proofreading exonuclease 
activity. If reactions with Vent polymerase were unsuccessful I turned to high fidelity 
Taq polymerase, which has an artificially added proofreading function. If this ampli-
fication again failed I alternatively used Phusion DNA polymerase or PfuUltra High-
Fidelity DNA polymerase. The latter was also used for the site-directed mutagenesis 
protocol since it provides robust amplification of long, complex targets. Gradient 
PCR was applied to determine the optimum annealing temperature. 
 
Vent PCR 
Vent DNA polymerase (New England Biolabs) 
Vent PCR was performed in a 100µl reaction volume containing the following com-
ponents: 
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72µl H2O  
10µl 10x ThermoPol Reaction Buffer  
 5µl 5mM dNTPs 
 5µl 10µM Primer 1 
 5µl 10µM Primer 2 
 2µl genomic DNA or plasmid template 
 1µl  Vent DNA Polymerase (1 unit) 
100µl 
 
In order to obtain appropriate PCR products a program with elongation time and 
temperature adapted to construct size, using 1 minute per kb of product, was per-
formed.  
 
PCR Program 
Temperature Minutes Cycles 
94°C 5 1 
94°C 
55°C 
72°C 
1 
2 
1min/kb 
 
30 
 
72°C 5 1 
10°C forever  
 
 
Taq High Fidelity (HiFi) PCR 
Platinum Taq HiFi DNA polymerase (Invitrogen)  
PCR with HiFi polymerase was performed in a 50µl reaction volume containing the 
following components: 
        36.8µl H2O  
 5µl 10x HiFi Taq Reaction Buffer  
 2µl 5mM dNTPs 
 1µl 100mM MgSO4 
 2µl 10µM Primer 1 
 2µl 10µM Primer 2 
 1µl genomic DNA 
0.2µl  HiFi Taq DNA Polymerase (1 unit) 
 50µl 
 
Elongation time was adapted to construct sizes using 1 minute per kb. 
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PCR Program 
Temperature Minutes Cycles 
94°C 2 1 
94°C 
55°C 
68°C 
0.5 
0.5 
1min/kb 
 
30 
 
68°C 5 1 
10°C forever  
 
 
PfuUltra High-Fidelity PCR 
PfuUltra High-Fidelity DNA polymerase (Stratagene)  
PCR with PfuUltra High-Fidelity polymerase was performed in a 50µl reaction vol-
ume containing the following components: 
39µl H2O  
 5µl 10x PfuUltra Reaction Buffer  
 1µl 5mM dNTPs 
 1µl 10µM Primer 1 
 1µl 10µM Primer 2 
 2µl genomic DNA 
 1µl  PfuUltra DNA Polymerase (2.5 units) 
 50µl 
 
Elongation time was adapted to construct sizes using 1 minute per kb. 
PCR Program 
Temperature Minutes Cycles 
94°C 5 1 
94°C 
55°C 
72°C 
0.30 
0.45 
1min/kb 
 
30 
 
72°C 10 1 
10°C forever  
 
 
Phusion PCR 
Phusion DNA polymerase (Finnzyms)  
PCR with Phusion polymerase was performed in a 50µl reaction volume containing 
the following components: 
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35µl H2O  
10µl 5x Phusion Reaction Buffer  
           1.5µl 5mM dNTPs 
  1µl 10µM Primer 1 
  1µl 10µM Primer 2 
  1µl genomic DNA 
           0.5µl  Phusion DNA Polymerase (1 unit) 
 50µl 
 
Elongation time was adapted to construct sizes using 1 minute per kb. 
PCR Program 
Temperature Minutes Cycles 
98°C 2 1 
98°C 
55°C 
72°C 
0.15 
1 
1min/kb 
 
35 
 
72°C 10 1 
10°C forever  
 
 
Gradient PCR 
Vent DNA polymerase (New England Biolabs) 
In order to evaluate optimal annealing temperatures for designed primers gradient 
PCR with temperatures ranging from 55-65°C (55.1, 55.4, 55.9, 56.9, 58, 59.3, 60.6, 
61.9, 63.4, 64.3, 64.9, 65.2°C) was performed. 12 tubes containing following ingre-
dients were prepared. Gradient PCR reactions were carried out using a VWR Quat-
trocycler.  
        36.5µl H2O  
 5µl 10x ThermoPol Reaction Buffer  
 2µl 5mM dNTPs 
          2.5µl 10µM Primer 1 
          2.5µl 10µM Primer 2 
 1µl genomic DNA 
          0.5µl  Vent DNA Polymerase (1 unit)  
50µl 
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PCR Program 
Temperature Minutes Cycles 
95°C 5 1 
95°C 
55-65°C 
72°C 
0.5 
0.5 
1 
 
30 
 
72°C 5 1 
10°C forever  
 
All PCR reactions, except gradient PCR, were carried out in a Bio-Rad DNAEngine. 
Finally, PCR products were analyzed by gel electrophoresis.and stored at -20°C. 
 
2.1.4 Colony PCR  
Taq DNA polymerase  
Colony PCR is a fast method to screen single colonies for the presence of cloned 
plasmid DNA. In the first step PCR reaction ingredients were mixed together. 
        13.3µl H2O  
 2µl 10x Taq buffer 
 1µl 5mM dNTPs 
 1µl 10µM Primer 1 
 1µl 10µM Primer 2 
          1.6µl 25mM MgCl2 
          0.1µl Taq DNA polymerase 
           20µl 
Then single colonies were picked using a sterile pipette tip and swirled in PCR reac-
tion and tips transferred to 3ml LB+ampicillin medium. 
 
PCR Program 
Temperature Minutes Cycles 
94°C 5 1 
94°C 
55°C 
72°C 
1 
2 
1min/kb 
 
30 
 
72°C 5 1 
10°C forever  
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PCR reactions were analyzed by gel electrophoresis, and LB+ampicillin cultures in-
cubated overnight at 37°C with shaking. Predicted insert-containing cultures were 
chosen and used for plasmid Mini Preparation. 
2.1.5 DNA Gel Electrophoresis 
In order to separate and analyze DNA, gel electrophoresis using 1% agarose gels was 
performed. Electrophoresis grade agarose (Invitrogen) was melted in 1x TAE buffer 
and cast and run in MGU-202T rigs (C.B.S.Scientific CO.) For DNA visualization 
SYBR
R
 Safe (Molecular Probes
TM
) was added according to the manufacturer‟s in-
structions. The loading buffer was 40% sucrose solution with bromophenol blue dye. 
The 1kb DNA Ladder (Invitrogen) served as a size marker. After loading gels were 
run at 110V for 30 minutes. DNA visualization was carried out in the Safe Imager 
(Invitrogen). 
2.1.6 DNA Gel Extraction  
To extract DNA fragments from agarose gels the QIAquick Gel Extraction kit 
(Qiagen) was used according to the manufacturer‟s instructions. For DNA elution 
30µl Buffer EB were used. 
2.1.7 Restriction digestion 
In order to generate sticky ends the PCR products and vector (pxS2-YFP) were di-
gested with the appropriate restriction endonucleases. During the project I used six 
different enzymes; BamHI, Bgl2, Bcl1, EcoRI, HindIII, NheI (all from New England 
Biolabs). Except Bgl2 all enzymes perform at maximum activity in NE Buffer 2. For 
Bgl2 I used NE Buffer 3. For digestion following components were mixed together: 
          30µl PCR product 
5µl 10x NE buffer 2 or NE buffer 3 (New England Biolabs) 
5µl 10x bovine serum albumin (BSA) 
2µl Enzyme 1 
2µl  Enzyme 2 
6µl H2O 
          50µl 
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10µl pxS2-YFP (approx. 10µg)  
2µl 10x NE buffer 2 (New England Biolabs) 
2µl 10x BSA 
1µl Enzyme 1 
1µl  Enzyme 2 
4µl H2O 
20µl 
 
These ingredients were gently mixed and incubated overnight at 37°C, or at 50°C for 
digestion with Bcl1. 
2.1.8 Test digestion  
For analysis of plasmid inserts restriction digests with appropriate enzymes were 
carried out. A single reaction mix consisted of: 
         5.4µl H2O 
2µl  plasmid DNA 
1µl  NE Buffer 2 
1µl 10x BSA 
         0.3µl Enzyme 1 
         0.3µl Enzyme 2 
          10µl 
 
This reaction was incubated at 37°C for 1½ hour followed by analysis using gel elec-
trophoresis. Plasmids carrying inserts of correct size were sent for sequencing to 
AGOWA genomics. 
2.1.9 PCR Purification 
To purify PCR products and vector DNA the QIAquick PCR Purification kit was 
applied according to the manufacturer‟s instructions. Eluted DNA was stored at -
20°C. 
2.1.10 CIP treatment of single cut vector DNA 
CIP removes phosphates from the 3‟ ends of DNA and is therefore useful to inhibit 
religation of singly-cut vectors. The following components were mixed together and 
incubated. 
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25µl vector DNA (pxS2-YFP) 
5µl 10x NE buffer 3 
2.5µl CIP (10U/µl; New England Biolabs) 
17.5µl H2O 
50µl 
 
These ingredients were gently mixed and incubated for at least 90min at 37°C. To 
remove residual enzymes a QIAquick PCR purification kit (Qiagen) was applied 
afterwards. 
2.1.11 Ligation reaction 
Ligation reactions were usually performed using a 7:1 ratio of insert to vector. Alter-
natively I measured DNA content by Nanodrop and applied 150ng insert and 50ng 
cut vector (3:1 ratio). For all reactions additionally a control reaction using water 
instead of insert, to control for ligation efficiency, was performed. The following 
components were mixed together and incubated for at least an hour at room tempera-
ture or at 16°C overnight. 
 
7µl cut insert 
1µl cut pxS2-YFP vector 
1µl 10x T4 DNA ligase buffer (New England Biolabs) 
1µl T4 DNA ligase (New England Biolabs) 
          10µl 
 
2.1.12 Preparation of competent Escherichia coli 
For preparation of competent E.coli (DH5α) 3 ml of LB-media were inoculated with 
DH5α cells and grown overnight at 37°C shaking. The next day this starter culture 
was used to inoculate 100ml of LB media. E.coli were grown until the OD600 reached 
0.45-0.55 which corresponds to mid log growth phase. In this stage bacteria are best 
to transform. The culture was incubated on ice for 15min. Afterwards falcons were 
centrifuged at 2500rpm for 15min at 4 °C. The supernatant was discarded and fal-
cons thoroughly drained. The pellet was then resuspended in 33ml (1/3 of original 
volume) RF1 and again incubated on ice for 15min. Then centrifugation at 2500rpm 
for 15min at 4°C followed. Supernatant and pellet were drained thoroughly and pellet 
resuspended in 8ml RF2 buffer. Finally aliquots of 250µl were flash frozen in liquid 
nitrogen und stored at -80°C. 
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            RF1:      RF2: 
 100mM KCL     10mM MOPS 
 50mM MnCl2-4H2O    10mM KCl 
 30mM Potassium acetate   75mM CaCl2-2H2O 
 10mM CaCl2-2H2O    15% w/v glycerol 
 15% w/v glycerol    pH 6.8 
 pH 5.8 
2.1.13 Transformation of competent E.coli 
Prepared competent E.coli (DH5α) were slowly thawed on ice. 10µl ligation reaction 
were added to 100µl bacteria and incubated for 5 min on ice. For transformation the 
DH5α cells were given a heat shock for 45 seconds at 42°C and then again placed on 
ice for 2 min. After this treatment 500µl LB medium were added to each sample and 
tubes were shaken at 37°C for an hour in order to give bacteria time for expression of 
the resistance marker. Recovered E.coli were spread out on prewarmed (1h, 37°C) 
LB+ampicillin plates and incubated overnight at 37°C. 
2.1.14 Bacterial culture 
For this project DH5α E.coli were used for all cloning procedures. Bacteria were 
grown at 37°C with 220rpm agitation in LB media containing antibiotic supplement 
(100µg/ml ampicillin) if necessary. When single colonies were required E.coli were 
cultured on LB+ampicillin plates. 
2.1.15 Plasmid Miniprep, Maxiprep and DNA sequencing 
Plasmid DNA was purified using the QIAgen Plasmid Mini Purification kit.  
Since Trypanosomes need high amounts of DNA for successful transfection, se-
quenced plasmids were further enriched by plasmid maxi prep (QIAgen Plasmid 
Maxi Purification kit). In the first step transformation was carried out as standard 
using 1µl of minprep DNA. The next day single colonies were picked and first cul-
tured in 3ml LB+ampicillin at 37°C. After approximately 6 hours this starter culture 
was used to inoculate 250ml media and bacteria were grown overnight with shaking 
at 37°C. The next day a maxiprep was carried out according to the manufacturer‟s 
instructions and DNA was eluted in 600µl EB buffer. 
Sequencing was performed by AGOWA genomics using 4 different primers; CLD41 
annealing upstream of the HindIII restriction site and the YFP-rev reverse primer 
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annealing within the YFP construct, as well as the EGFP-C1-F forward primer and 
the pxS2-rev (reverse) surrounding the BamHI and EcoRI sites (Fig. 2.1.2). 
2.1.16 Site-directed mutagenesis 
Site-directed mutagenesis was carried out using the QuickChange Site-Directed 
Mutagenesis protocol from Stratagene. First mutagenic primers containing the ap-
propriate point mutation were designed according to protocol guidelines. As a tem-
plate various concentrations of DNA (X=5ng, 10ng, 20ng, 50ng) while keeping the 
primer concentration constant were used for amplification with PFU Ultra poly-
merase. 
PCR was performed in a 50µl reaction volume containing the following components: 
 
   5µl 10x PFU Ultra Reaction Buffer  
 1µl 5mM dNTPs 
        1.25µl 10µM Primer 1 
        1.25µl 10µM Primer 2 
 1µl PFU Ultra polymerase 
 Xµl template DNA 
     40.5-Xµl H2O  
50µl   
 
PCR Program 
 
Temperature Minutes Cycles 
95°C 0.5 1 
95°C 
55°C 
68°C 
0.5 
1 
7 
 
12 
 
10°C forever  
 
PCR products were digested with DpnI at 37°C for 1 hour to digest the non-
muatgenic parental strands. This reaction was then directly used to transform bacteria 
as described before. 
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2.2 Cell culture and Transfection 
Procyclic T.brucei 29.13 or T.brucei 427 cells were transiently transfected and ana-
lyzed by immunofluorescence microscopy to determine subcellular localizations. 
Line 29.13 was generated from T.brucei 427 and expresses T7 RNA polymerase and 
tetracycline repressor along with linked hygromycin and neomycin resistance genes 
(Wirtz et al., 1998). For our experiments these circumstances basically did not make 
any difference. For availability reasons first T.brucei 29.13 cells were used then we 
switched to T.brucei 427 cells. 
2.2.1 Cell culture  
The T.brucei 29-13 cell line and T.brucei 427 cell line were maintained in SDM-79 
media supplemented with haemin and 15% fetal calf serum, 200µM Glutamine, 
10µg/ml Pen/Strep and 10µg/ml Gentamicin at 28°C in the presence of 15µg/ml 
G418, 50µg/ml hygromycin (T.brucei 29-13) or without hygromycin or G418 
(T.brucei 427). Trypanosomes were usually grown in 7ml suspension and split daily. 
2.2.2 Cell counting 
Cells were counted by using a Z2 Coulter Particle Count and Size Analyser from 
Beckman Coulter. 
2.2.3 Transient transfection 
For transient transfection approximately 5x10
7
 cells were used. Cells were centri-
fuged at 3000rpm for 5 min at 4°C. The pellet was resuspended in 10ml Cytomix and 
again centrifuged. The final cell pellet was resuspended in 500µl Cytomix and trans-
ferred into a 0.4cm electroporation cuvette. 50µg DNA was added and well mixed 
before electroporation with 2x 10s pulses (1500V, 25µF) using a GenePulser Xcell 
(Bio-Rad). Transfected cells were transferred to 7ml media and grown overnight at 
28°C. 
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Cytomix: 
120mM KCL 
0.15mM CaCl2 
10mM K2HPO4 
25mM Hepes (pH 7.6) Molecular Biology Grade 
2mM EGTA, pH 8 
5mM MgCl2  
2.2.4 Generation of a stable cell line 
In order to create a stable cell line pxS2-YFP vector containing the target sequence 
was digested with Nsi1 to linearize it. Linearization is important to enable double 
homologous recombination at the tubulin locus. The following components were 
mixed together and incubated at 37°C overnight. 
95µl Maxiprep plasmid DNA (60µg) 
15µl 10x NE buffer 3 (New England Biolabs) 
15µl 10x BSA 
  8µl Nsi1 (New England Biolabs) 
17µl H2O 
          150µl 
 
Since the amount of DNA is too much for usage of the Qiagen kit (column capacity 
is 10µg) I purified the linearized DNA by mixing the following components together. 
 
150µl digested plasmid DNA  
120µl H2O 
  30µl 3M NaAc (10% total)  
750µl 100% Ethanol (EtOH) (2.5 Volume)  
          1050µl 
This mix was incubated at -20°C for 20 min and then centrifuged at 13000rpm for 15 
min at 4°C. After washing with 70% ethanol (EtOH) the tube was again centrifuged 
at 13000rpm for 1 min at 4°C. The DNA pellet was then air dried for 30 min and 
resuspended in 60µl water. 
For the transfection 5x10
7
cells were transfected with 25µg linearized DNA. For re-
covery and DNA integration the cells were incubated at 28°C over night. The next 
day cells were spread in blasticidin containing media (pxS2-YFP carries blasticidin 
resistance cassette) by serial dilution starting from 1:2, 1:5 and 1:10 diluted cells. 
The 96 well plates were then incubated at 27°C, 5% CO2 and checked daily. After 5-
14 days a cloudy growth front was visible. At about 20 days after plating the growth 
  41 
front had proceeded to half of the plate. Clonal populations growing at least 4 wells 
in front of the growth front were taken to a 24 well plate and 1ml selection media 
was added on top. The next day 1ml of selection media was added. After overnight 
incubation the cells were added to 4ml selection media in 25cm
2
 flasks. Trypano-
somes were then screened for the incorporation of the YFP-construct by im-
munofluorescence microscopy, PCR from genomic DNA and Western blotting. 
 
2.3 Immunofluorescence 
Trypanosomes were transfected with maxiprep DNA by electroporation and grown at 
28°C overnight. The next day Trypanosomes transiently expressing the recombinant 
proteins were harvested and either fixed with MeOH or PFA. Detergent-extracted 
cytoskeletons were prepared using extraction buffer and fixed with PFA. The cells 
were then incubated with appropriate antibodies and analyzed by immunofluores-
cence microscopy. 
2.3.1 Fixation and blocking 
First 80µl cell suspension per coverslip was harvested by centrifugation at 6000rpm 
for 1 min at room temperature. The cell pellet containing transfected Trypanosomes 
was twice washed in 1xPBS and then transferred to a 13mm coverslip placed in a 24-
well tissue culture plate. For attachment of cells centrifugation at 3000rpm for 4 min 
was used. 
PFA-Fixation 
For PFA fixation Trypanosomes attached to coverslips were incubated in a 4% PFA 
solution in PBS for 20 min at room temperature. Once washed with 1xPBS, 0.25% 
Triton X-100 solution in PBS was added and incubated for 5 min. This detergent 
treatment is necessary to permeabilise the plasma membrane and enable antibody 
binding. Then coverslips were washed 3 times with 1xPBS and cells visually in-
spected for attachment and healthy cell morphology. For blocking, the cells were 
incubated in 3% BSA (in 1xPBS) for 30min on a rocking stage. 
MeOH- Fixation 
MeOH fixation was performed by incubating coverslips with pre-chilled MeOH for 
15min at -20°C. Due to its chemical similarity to water methanol replaces the water 
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molecules in the cells. When MeOH-treated cell are exposed to air the alcohol 
quickly evaporates and the cells will dry out. In order to avoid this cells were washed 
with 1xPBS by continuous infusion and aspiration. Finally coverslips, as PFA fixed 
cells, were incubated in blocking solution. 
Extracted cytoskeletons + PFA-Fixation 
To obtain detergent-extracted cytoskeletons, Trypanosomes were attached to cover-
slips and incubated in extraction buffer ( “PEME”: 0.5% NP4O, 2mM EGTA, 
0.1mM EDTA, 1mM MgSO4, 0.1M PIPES-NaOH, pH 6.9) for 5 min at room tem-
perature. They were then washed 3 times with 1x PBS and fixed with PFA according 
to the standard protocol. 
2.3.2 Antibody binding and Mounting 
Primary antibody was added to a humidified chamber at the required dilution (in 
1xPBS). Coverslips were transferred onto antibody solution drops and incubated for 
1 hour at room temperature. After incubation washing with 1x PBS by 2x rinses and 
finally 10 min incubation on the rocking stage was performed. Fluorophore-coupled 
goat anti-rabbit/ anti-mouse secondary antibodies diluted in PBS as appropriate (Mo-
lecular Probes) were added to the chamber. Again coverslips were placed on top and 
incubated for 1 hour at room temperature. To stain DNA coverslips were directly 
transferred to 4‟,6-diamidin-2-phenylindol (DAPI) solution, a DNA intercalating 
substance (1:1000 in PBS). 15 min later DAPI solution was removed by washing 3x 
with 1xPBS. Finally coverslips were mounted with Fluoromount G (Electron Mi-
croscopy Sciences). Later on instead of DAPI staining I used Fluoromount containing 
DAPI from Southern Biotech. Coverslips were stored at 4°C until used. 
2.3.3 Immunofluorescence microscopy 
Epifluorescence images were obtained using an inverted microscope (Axio Observer 
Z1, Carl Zeiss MicroImaging Inc.) equipped with a PCO 1600 camera (PCO) and 
using the manufacturer‟s drivers in a custom C++ program. 
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2.4 Protein methods  
In order to confirm expression of YFP fusion proteins I performed Western blot 
analysis of whole cell lysates from the MORN-family. For the TbMORN1 trunca-
tions, fractionation experiments were carried out by extraction with 0.5% NP40 fol-
lowed by centrifugation at 14000rpm for 5 min. This resulted in three different sam-
ples: the input taken before centrifugation, the supernatant containing the soluble 
cytoplasmic & membrane fraction and the pellet containing the insoluble cytoskeletal 
fraction. Therefore the supernatant fraction contains cytoplasmic proteins and the 
pellet fraction represents cytoskeletal-associated proteins. Equal fractions were ana-
lyzed by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
and Western blot. By using α-GFP antibodies expression and tracking of recombi-
nant proteins were examined. To check whether the endogenous MORN1 traffics to 
the cytoplasmic or cytoskeletal fraction membranes were treated with α-MORN1 
antibodies. These blots were used as a positive control for biochemical fractionation 
experiments. 
2.4.1 Whole cell lysate preparation 
For Western blot analysis total cell lysates were prepared. Cell concentration was 
measured and a 5ml sample was centrifuged at 3000rpm for 5min at 4°C. The pellets 
were taken up in 10ml 1xPBS and again centrifuged. In the next step pellets were 
resuspended in 1ml 1xPBS, transferred to 1.5ml Eppendorf tubes, and again pelleted 
(6000rpm, 1min). Finally cells were taken up in sodium dodecyl sulphate (SDS)-
loading buffer such that the final concentration was 2x10
5
cells/µl. To denature pro-
teins the samples were boiled for 10 min. Cell lysates were stored at -20°C. 
SDS-Loading Buffer 
2ml 10% SDS 
2ml 0.5M Tris-HCl pH 6.7 
3ml 50% Glycerol 
1ml Beta-mercaptoethanol 
As required Bromophenoblue 
2.4.2 Biochemical fractionation 
Cells were grown to stationary phase, concentration was measured and a 7ml sample 
centrifuged at 3000rpm for 5min at 4°C. The pellets were taken up in 1ml 
PEME+COMPLETE (PEME buffer supplemented with protease inhibitor tablets) 
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and again centrifuged. In the next step pellets were resuspended in 200µl extraction 
buffer (0.5%NonidetP-40 in PEME) and incubated for 30 minutes at room tempera-
ture on a roller. After incubation 10µl samples, called “Input” (representing 5% of 
volume) were taken. Extracted cells were then centrifuged for 5 min at 14000rpm at 
room temperature. Supernatant and pellets were separated and the pellets taken up in 
200µl extraction buffer (1%NonidetP-40 in PEME). Of these 2 fractions 10µl sam-
ples, referred to P1 and SN1 were obtained. By adding 30µl SDS-LB final volumes 
of 40µl representing 5% were achieved. To denature proteins the samples were 
boiled for 10 min. Fractionated cell lysates were stored at -20°C. 
2.4.3 SDS-Page  
In order to separate proteins according to their sizes, SDS-polyacrylamide gel elec-
trophoresis was performed. Generally a 15% or 12% resolving and 4% stacking gel 
were cast and run in Mini-PROTEAN Tetra Cells according to the manufacturer‟s 
instructions (Bio-Rad). 
Resolving gel (1 gel)      
Resolving gel  15% 12% Stacking gel 4% 
 30% Bis-Acrylamide 5ml 4ml 1.3ml 
Tris 1.5M pH8,8 2.5ml 2.5ml - 
Tris 0.5M pH6,8 - - 2.5ml 
H2O 2.4ml 3.4ml 6.1ml 
10% SDS 100µ
l 
100µ
l 
100µl 
 
 
Shortly before pouring the gel polymerization was started with 100µl 10%APS and 
10µl TEMED. SDS gels were usually run at 90mA for 50 min. 
2.4.4 Western blot  
The transfer of proteins from the SDS-gels to nitrocellulose membranes was per-
formed using Mini Trans-Blot Electrophoretic Transfer cells (Bio-Rad). Therefore 
the “sandwich”, containing in buffer soaked gel, membrane, whatman papers and 
fiber pads, was assembled. This sandwich was placed into the blotting cassette. Blot-
ting took place for 2 hours at 350mA chilled with ice at 4°C. 
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In order to check transfer quality, nitrocellulose membranes were stained with Pon-
ceau´s solution (0.2% Ponceau‟s, 10% acetic acid). After a few minutes this reagent 
non-specifically stains the membrane but destaining using water reveals transferred 
proteins from total cell lysates. 
To avoid non-specific signals from antibodies bound to nitrocellulose, membranes 
were blocked with milk solution (10% milk powder, 0.3% TWEEN-20 in 1xPBS) for 
at least 30 min. Afterwards the membranes were placed into the first antibody solu-
tion (diluted in blocking solution) and incubated for 1 hour at room temperature on 
the rocking stage. Then membranes were washed 3 times in 1xPBST (0.3% 
TWEEN-20 in PBS) for 5 min to remove any unbound antibodies. The membranes 
were placed into secondary antibody (horseradish peroxidase-conjugated goat anti-
rabbit/anti-mouse) solution and incubated for 1 hour on the rocking stage. In the next 
step the membranes were again washed 3 times in 1xPBST for 5 min. 
For visualization of blots the enhanced chemiluminescence kit (Pierce) was used 
according to the manufacturer‟s instructions. X-Ray films (BioMax MS Film, Ko-
dak) were exposed for variable times (a few seconds up to 20 min) and developed. 
 
2.5 Bioinformatics  
2.5.1 Immunofluorescence microscopy 
Image processing was carried out using ImageJ and Adobe Photoshop CS3 software. 
2.5.2 Databases, Internet resources  
T.brucei GeneDB: Data base which provides the latest sequence data and annotation 
for a range of pathogens including Trypanosomes. www.genedb.org/genedb/tryp 
TriTrypDB: TriTryp data base includes a genomic resource for Trypanosomes. 
http://tritrypdb.org/tritrypdb/ 
NEB: This sites gives information about products (restriction enzymes, polymerases) 
and applications (PCR conditions) from New England Biolabs. 
http://www.neb.com/nebecomm/default.asp 
  46 
2.5.3 Tools and Software 
JPred is a consensus method for protein secondary structure prediction. 
http://www.compbio.dundee.ac.uk/www-jpred/ 
NCBI provides BLAST sequence analysis service for DNA and protein. 
http://www.ncbi.nlm.nih.gov/blast/Blast.cgi 
Hydrophobicity plot: Through this tool plots demonstrating hydrophobic character of 
a protein sequence can be obtained. These plots display the distribution of polar and 
apolar residues along a protein sequence. This analysis is commonly used for the 
prediction of membrane-spanning segments (highly hydrophobic) or regions that are 
likely exposed on the surface of proteins (hydrophilic domains). To generate data for 
a plot the sequence is scanned with a moving window of fixed size. At each position 
the mean hydrophobic index of the amino acids within the window is calculated and 
plotted as the midpoint of the window. In the Kyte-Doolittle scale hydropobic re-
gions achieve positive values. Negative values have hydrophilic character. The win-
dow size refers to the number of amino acids examined at a time to determine ap-
point of hydrophobic character. So one should choose a window that corresponds to 
the expected size of the structural motif. 
http://www.vivo.colostate.edu/molkit/hydropathy/index.html 
Mitoprot II: 
Mitoprot II produces an output using a set of parameters that calculate the N-terminal 
protein region that can support a mitochondrial targeting sequence and a predicted 
cleavage site. Thus, it searches for the existence of two close glutamic acids or aspar-
tic acids takes in account the isoelectric point, the enrichment of positively charged 
residues, the paucity of acidic residues and further parameters (Claros and Vincens, 
1996). This program has been used before to predict possible mitochondrial targeting 
sequences in Leishmania major (Li et al., 2007). 
http://ihg.gsf.de/ihg/mitoprot.html 
 
CSS-Palm: Prediction of palmitoylation sites: 
http://csspalm.biocuckoo.org/ 
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3 Results 
3.1 The MORN-repeat protein family  
In T.brucei there are 17 other proteins containing MORN-repeats which are all un-
characterized so far (Fig.3.1.1). In this project I cloned the MORN-repeat proteins 
and screened for possible bilobe localization. Two of these proteins, Protein 1 and 7, 
were previously detected in the flagellar proteome (Broadhead et al., 2006). Protein 
3, 4, 5, 6, 7 and 9 were found in the plasma membrane and cytoskeletal fraction of 
bloodstream form cells (Bridges et al., 2008). Additionally Proteins 2, 6 and 8 have 
potentially interesting features- like a VPS9, kinase, or kinesin motor domain respec-
tively. Protein 12 has predicted transmembrane domains and Protein 17 carries a zinc 
finger motif. 
 
Fig. 3.1.1 The family of MORN-repeat proteins in T.brucei. 
Protein maps of MORN-repeat family members showing predicted protein domains. 
Green box: MORN-repeat; yellow box: VPS9 domain; orange box: kinesin motor 
domain; red box: kinase domain; purple box: transmembrane domain; blue box: zinc 
finger motif. 
  48 
3.2 General experimental strategy  
The general experimental strategy was to clone each ORF into the pxS2-YFP expres-
sion vector (Fig.2.1.1) using standard molecular biology techniques. During cloning 
the YFP tag was placed at the 5‟ or 3‟ end of the cloned gene depending on the avail-
ability of restriction sites (Table 3.2-1). 
 
Name Gene ID YFP gene at Restriction 
site(s) 
Notes 
Protein 1 Tb927.8.3780 5‟end BamH1/EcoR1 Q49H, A152S 
Protein 2 Tb927.3.2430 5‟end BamH1/BamH1 A59V, A63P, 
A303M, 
M364T, 
E767K, F772L, 
Q825E 
Protein 3 Tb927.7.3310 5‟end BamH1/EcoR1  
Protein 4 Tb927.3.2890 3‟end Hind3/Nhe1  
Protein 5 Tb927.10.6230 3‟end Nhe1/Nhe1  
Protein 6 Tb927.10.1457
0 
3‟end Hind3/Nhe1  
Protein 7 Tb927.7.6910 3‟end Hind3/Nhe1 Q221M, P493A 
Protein 8 Tb927.10.1035
0 
3‟end Hind3/Nhe1 V310A, 
D315N, D466G 
Protein 9 Tb11.02.5030 5‟end BamH1/EcoR1 R21H, T264I, 
P380T 
Protein 10 Tb927.2.5040 5‟end BamH1/EcoR1  
Protein 11 Tb11.01.1460 5‟end BamH1/EcoR1  
Protein 12 Tb927.5.3880 3‟end Hind3/Nhe1 S580P 
Protein 13 Tb927.7.3400 3‟end Hind3/Nhe1  
Protein 14 Tb927.1.1910 5‟end Bcl1/EcoR1  
Protein 15 Tb927.3.4270 3‟end Hind3/Nhe1 S210L, Y268H, 
S549G, M669L, 
V706A, 
R761K, E823D, 
N830S 
Protein 16 Tb927.1.740 5‟end BamH1/EcoR1  
Protein 17 Tb927.7.530 3‟end Hind3/Nhe1  
Table 3.2-1 Summary of cloning  
These constructs were used to transiently transfect procyclic T.brucei cells. Localiza-
tion of each protein were then investigated by immunofluorescence microscopy. 
Whole cells and extracted cytoskeletons were fixed with PFA or MeOH.  α-GFP an-
tibodies were used to amplify the YFP signal. Protein localizations were confirmed 
by costaining with antibodies against marker proteins- α-PFRA for PFR, YL1/2 for 
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basal body, and α-LRRP1 for bilobe. Protein expression was further checked by 
Western blotting of whole cell lysates using α-GFP antibodies. 
3.2.1 Protein 1, Tb927.8.3780 
Tb927.8.3780 is a 501 amino acid, approximately 20kDa protein with 3 MORN-
repeats (Fig. 3.2.1). The protein was previously detected in the flagellar proteome 
(Broadhead et al., 2006). Sequencing results on the cloned construct showed 2 point 
mutations, specifically Q49H and A152S. Since these two aberrations were not found 
within the MORN-repeats we expected them not to strongly influence protein activ-
ity. Furthermore both point mutations were also detected in repeated PCR cloning 
reactions and therefore we suggest that they might be real. Generally, some natural 
variations between lab populations and the genome from GeneDB are to be expected. 
 
Fig. 3.2.1 Schematic of Protein 1 (Tb927.8.3780). 
MORN-repeats are represented by green boxes. 
Immunofluorescence studies of Protein 1 using α-GFP antibodies revealed a whole 
cell labelling in MeOH- and PFΑ-fixed cells suggesting a pool of YFP-tagged pro-
teins in the cytosol (Fig.3.2.2 A and B). Detergent-extracted cytoskeletons showed 
that the recombinant protein was present on the flagellum (Fig.3.2.2 C). This is con-
sistent with the annotation of Protein 1 in the flagellar proteome. To better determine 
the localization of YFP-Protein 1 a second set of experiments using α-PFRA antibod-
ies to label the PFR was performed. The α-GFP signal was found on top of the PFRA 
staining and furthermore extended beyond the PFR (Fig.3.2.2 D). This suggested that 
the YFP-tagged protein localized to the flagellar axoneme. 
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Fig. 3.2.2 Localization of YFP-Protein 1 (Tb927.8.3780) examined by im-
munofluorescence microscopy. 
Transiently transfected procyclic Trypanosomes fixed with either (A) PFA or (B) 
MeOH showed cytosolic labelling with α-GFP antibodies. (C,D) Detergent-extracted 
cytoskeletons from YFP-Protein 1 expressing cells were fixed with PFA and labelled 
with α-GFP and α-PFRA antibodies (D). The recombinant protein appeared to be 
present on the flagellum on top of the PFR (*) and extended beyond the PFR towards 
the kinetoplast (arrow). Nuclear and kinetoplast DNA were in all cases labelled with 
DAPI. Bars, 5µm. 
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3.2.2 Protein 2, Tb927.3.2430 
Tb927.3.2430 is a 103kDa protein composed of 4 MORN-repeats, and has a VPS9 
domain near the C-terminus (Fig.3.2.3). The latter is present in yeast vacuolar sorting 
protein 9 and is a Rab5 Guanidine exchange factor (GEF). Amplification of the Pro-
tein 2 ORF with Vent polymerase was unsuccessful. Magnesium concentrations were 
varied from 2-8mM but no product could be obtained. For this reason I used a High 
Fidelity Taq DNA polymerase which has an artificially added proofreading ability to 
minimize the misincorporation rate of normal Taq polymerase. Using High Fidelity 
Taq and a higher annealing temperature of 58°C a 2763bp product was amplified. 
The ORF was ligated into the expression vector using only a single restriction site 
and with the YFP tag at the 5‟end. Sequencing revealed that the initial clones carried 
7 point mutations (A59V, A63P, A303M, M364T, E767K, F772L, Q825E) which 
are not found within MORN-repeats but the last was found within the VPS9 domain. 
In order to obtain a mutation-free PCR product I tried two further polymerases, Phu-
sion and PFU Ultra. Except for the first mutation, A59V, all others were found in a 
repeated PCR and therefore we supposed them to be real in the T.brucei culture. 
 
Fig. 3.2.3 Schematic image of Protein 2 (Tb927.3.2430). 
The 103kDa protein is composed of 4 MORN-repeats and has a VSP9 domain near 
the C-terminus. 
Procyclic cells were treated for immunofluorescence as standard. In intact cells, a 
cytoplasmic labelling pattern was observed (Fig.3.2.4 A and B). This suggested that 
the fusion protein was expressed and present in the cytosol. In detergent extracted 
cytoskeletons no specific signal was obtained in two independent transfections (data 
not shown). Therefore I classified YFP-Protein 2 as a cytosolic protein. 
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Fig. 3.2.4 Trypanosomes expressing YFP-Portein 2 (Tb927.3.2430). 
Cells were fixed with PFA (A) or MeOH (B) 15 hours after transfection and labelled 
with α-GFP antibodies. Nuclear and kinetoplast DNA were labelled with DAPI. Un-
der both fixation conditions whole cell staining was observed suggesting that a large 
pool of cytosolic recombinant proteins was present. Bars, 5µm. 
3.2.3 Protein 3, Tb927.7.3310 
Tb927.7.3310 was detected in the plasma membrane and cytoskeletal fraction of 
bloodstream form cells (Bridges et al., 2008). The 1071bp long gene coding for 3 
MORN-repeats is located on chromosome 7 (Fig.3.2.5). 
 
Fig. 3.2.5 Schematic of Protein 3 (Tb927.7.3310). 
Sequencing of cloned DNA showed that the amplified inserts contained a deletion at 
base 63. This region of Tb927.7.3310 locus is composed of a stretch of ten As coding 
for multiplephenylalanine residues and therefore the polymerase is probably at risk of 
skipping bases and introducing mutations. This deletion leading to a frameshift 
would alter the sequence and encode a completely different protein. Therefore a sec-
ond amplification of Protein 3 by PCR was started but sequencing results again 
showed the same aberration. Unfortunately trials with Phusion and PFU Ultra poly-
merase were similarly unsuccessful. Therefore site-directed mutagenesis to introduce 
the missing adenosine was performed. Sequencing of the mutagenic plasmid revealed 
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that it contains one mutation, K343E. Since this aberration was also detected in a 
repeated PCR reaction I considered it to be present in the Trypanosome genome of 
the culture. 
Immunofluorescence microscopy revealed cytosolic labelling in PFA and MeOH- 
fixed cells (Fig.3.2.6 A and B). This suggested that the recombinant protein was ex-
pressed and present in the cytosol. Trypanosomes treated with extraction buffer 
showed that YFP-Protein 3 was found on the flagellum. The localization is likely to 
be to the axoneme since the α-GFP staining was observed on top of the PFR and ex-
tended beyond it towards the kinetoplast (Fig.3.2.6 C). 
 
Fig. 3.2.6 YFP-Protein 3 (Tb927.7.3310) expressing cells examined by im-
munofluorescence microscopy. 
Procyclic Trypanosomes were fixed with (A) PFA or (B) MeOH. α-GFP antibodies 
were used to enhance the YFP signal. Nuclear and kinetoplast DNA were labelled 
with DAPI. Uniform whole cell labelling was observed suggesting that there was a 
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pool of recombinant protein in the cytosol. (C) Detergent extracted cytoskeletons 
reveal that the tagged protein was present on the flagellum on top of the PFR (*) and 
extended beyond the PFR (arrow). Bars, 5µm. 
3.2.4 Protein 4, Tb927.3.2890 
Tb927.3.2890 is a 37kDa protein with 6 MORN-repeats (Fig.3.2.7). This 322 amino 
acid long polypeptide was detected in the plasma membrane and cytoskeletal fraction 
of bloodstream form cells (Bridges et al., 2008). 
 
Fig. 3.2.7 Protein 4 (Tb927.3.2890). 
Trypanosomes transiently expressing the YFP-tagged recombinant protein fixed with 
MeOH or PFA showed cytosolic staining after labelling with α-GFP antibodies 
(Fig.3.2.8 A and B). Detergent-extracted cytoskeletons showed that the fusion pro-
tein was present on the flagellum (Fig.3.2.8 C). By costaining with PFRA antibodies 
it was further shown that the YFP-tagged protein was probably present on the 
axoneme. The α-GFP signal was found on a structure lying on top of the PFR and 
extended beyond it (Fig.3.2.8 D). 
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Fig. 3.2.8 Protein 4-YFP (Tb927.3.2890) is a flagellar protein. 
(A) PFA fixed Trypanosomes labelled with α-GFP antibodies showed cytosolic 
staining. (B) Uniform whole cell staining was also observed for MeOH-fixed cells. 
(C, D) Detergent-extracted Trypanosomes fixed with PFA and labelled with α-GFP 
displayed a clear flagellum staining. (D) The costaining with PFRA revealed that 
Protein 4-YFP was probably present on the axoneme as labelling was found on top of 
the PFR (*) and extended beyond the PFR (arrow). Nuclear and kinetoplast DNA 
were labelled with DAPI. Bars, 5µm. 
3.2.5 Protein 5, Tb927.10.6230 
For amplification of the Tb927.10.6230 gene all trials with Vent DNA polymerase, 
even with magnesium concentrations ranging from 2-8mM, were unsuccessful. Us-
ing High Fidelity Taq DNA polymerase finally gave rise to a 2073bp long product. 
The 77kDa protein (Fig.3.2.9) was previously detected in bloodstream plasma mem-
brane and cytoskeletal fraction (Bridges et al., 2008). 
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Fig. 3.2.9 Protein 5 (Tb927.10.6230) the primary structure contains 17 MORN-
repeats. 
Transient expression of Protein 5-YFP was challenging too since no cells expressing 
the recombinant protein were observed (n=2). For the third transfection I used cells at 
a concentration of 4x10
6
 cell/ml which means that cells were in mid log phase and 
therefore should take up DNA easier than in stationary phase. But even so no trans-
fected cells were observed. As a consequence I decided to generate a stable cell line. 
Unfortunately no clones were obtained in the selection media. A second transfection 
lead to one clone growing in selection media, but expression of the YFP-tagged pro-
tein was not observed by IF. Western blots of cell lysates from the clonal population 
were also negative. PCR using primers annealing to the 3‟end of the ORF of Protein 
5 and the 5‟end of the YFP gene was unsuccessful. The basticidin gene in contrast 
was successfully amplified by PCR. This means that the cells acquired the resistance 
gene but not the YFP cassette. From all these circumstances I considered that the 
YFP-tagged protein might be toxic for the cells. 
3.2.6 Protein 6, Tb927.10.14570 
The approximately 80kDa protein contains 5 MORN-repeats and a kinesin motor 
domain (Fig.3.2.10). Kinesins are microtubule-associated motor proteins that can 
play a role in organelle transport. Protein 6 was additionally detected in both the 
plasma membrane and cytoskeletal fractions of bloodstream Trypanosomes (Bridges 
et al., 2008). 
 
Fig. 3.2.10 Schematic of Protein 6 (Tb927.10.14570). 
The kinesin motor domain is shown in orange. 
Anti-GFP antibodies binding to the YFP tag labelled a pool of cytosolic recombinant 
proteins in PFA- and MeOH-fixed cells (Fig.3.2.11 A and B). In detergent-extracted 
cytoskeletons of Trypanosomes fixed with PFA Protein 6-YFP was found on the 
flagellar axoneme (Fig.3.2.11 C). This was shown by costaining with α-PFRA anti-
bodies where the α-GFP staining was found on top of the PFR and extended beyond 
it towards the kinetoplast (Fig.3.2.11 D). 
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Fig. 3.2.11 Localization of Protein 6-YFP (Tb927.10.14570) examined by im-
munofluorescence microscopy. 
Nuclear and kinetoplast DNA were labelled with DAPI. Transiently transfected Try-
panosomes fixed with (A) PFA or (B) MeOH showed cytoplasmic α-GFP labelling. 
(C) Detergent-extracted cytoskeletons from Protein 6-YFP expressing cells were 
fixed with PFA. Labelling of α-GFP was observed on the flagellum. (D) Costaining 
with PFR binding antibodies. Protein 6-YFP was found on a structure which lied on 
top of the PFR (*) and extended beyond the PFR (arrows). Bars, 5µm. 
 
3.2.7 Protein 7, Tb927.7.6910 
Protein 7 was also detected in the flagellum proteome. It was also found in the 
bloodstream plasma membrane and cytoskeletal fraction (Bridges et al., 2008) and 
contains 5 MORN-repeats (Fig.3.2.12). For amplification Hifi Taq polymerase was 
used and 2 point mutations (Q221M, P493A) outside MORN-repeats were detected. 
 
Fig. 3.2.12 Schematic of Protein 7. 
The expression patterns in PFΑ- and MeOH-fixed cells were a whole cell labelling 
(Fig.3.2.13 A and B). Detergent-extracted cytoskeletons from Protein 7-YFP trans-
fected cells show flagellum labelling with localization on the axoneme. Costaining 
with α-PFRA antibodies showed that the α-GFP labelling was found on top of the 
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PFR and extended beyond it towards the kinetoplast (Fig.3.2.13 C). Therefore Pro-
tein 7 probably localizes to the axoneme. 
 
 
Fig. 3.2.13 Trypanosomes transiently expressing Protein 7-YFP (Tb927.7.6910). 
(A) PFA- or (B) MeOH-fixed cells showed cytosolic localization. (C, D) Detergent-
extracted cytoskeletons revealed distinct flagellar staining. Costaining with α-PFRA 
antibodies showed that the YFP-tagged protein was lying on top of the PFR(*) and 
extended beyond it (arrows) towards the kinetoplast. Bars, 5µm. 
3.2.8 Protein 8, Tb927.10.10350 
The 66.7kDa protein Tb927.10.10350 is composed of 7 MORN-repeats and a kinase 
domain which is a predicted serine/threonine kinase (Fig.3.2.14). 
Sequencing of the clned gene revealed 3 point mutations: V310A, D315N, D466G. 
None were found within a MORN-repeat but the last was within the kinase domain. 
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Fig. 3.2.14 Schematic of Protein 8 (Tb927.10.10350). 
The kinase domain is shown in red. 
A bright green whole cell staining was observed in PFΑ- and MeOH-fixed cells 
(Fig.3.2.15 A and B). In detergent-extracted cytoskeletons a punctate structure was 
recognized by α-GFP antibodies (Fig.3.2.15 C). This pattern was observed in many 
cells at a position next to the kinetoplast which suggested basal body staining. The 
fact that 2N2K cells showed 2 distinct punctae further supported this idea (Fig.3.2.15 
C‟). 
The α-GFP signal strongly overlapped with the basal bodies as labelled with YL1/2 
monoclonal antibody (Fig.3.2.15 D). I concluded that Protein 8-YFP is present at the 
basal body. 
 
Fig. 3.2.15 Protein 8-YFP (Tb927.10.10350) localized to the basal bodies. 
Cells were fixed with (A) PFA or (B) MeOH and labelled with α-GFP antibodies. 
Nuclear and kinetoplast DNA were labelled with DAPI. Whole cell staining was ob-
served under both conditions. (C) Detergent-extracted cytoskeletons from Protein 8-
expressing cells fixed with PFA and labelled with α-GFP antibodies. A punctate 
structure (arrowheads) was recognized by α-GFP antibodies that due to its consistent 
position near the kinetoplast (arrow) might be basal body staining. (D) Costaining 
showed that Protein 8 and YL1/2 significantly overlap (arrowhead). Bars, 5µm. 
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3.2.9 Protein 9, Tb11.02.5030 
Tb11.02.5030 is a 72,56kDa protein which contains 10 MORN-repeats (Fig.3.2.16). 
This protein was detected in the plasma membrane fraction of blood stream form 
cells (Bridges et al., 2008). Sequencing revealed that this clone carries three muta-
tions (R21H, T264I, P380T). 
 
Fig. 3.2.16 Schematic of Protein 9 (Tb11.02.5030). 
Immunofluorescence studies of Protein 9 showed whole cell labelling in intact cells 
which suggested that the protein was present in the cytosol (Fig.3.2.17 A and B). 
Cells treated with extraction buffer and fixed with PFA displayed flagellum labelling 
(Fig.3.2.17 C). For specific localization a second set of experiments with PFR bind-
ing antibodies was performed. The α-GFP staining was found on a structure which 
was found on top of the PFR and extended beyond it (Fig.3.2.17 D). Therefore Pro-
tein 9 probably localizes to the flagellar axoneme. 
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Fig. 3.2.17 Localization of YFP-Protein 9 (Tb11.02.5030) 
Transiently transfected cells were fixed with (A) PFA or (B) MeOH and labelled 
with α-GFP antibodies. Nuclear and kinetoplast DNA were visualized with DAPI. 
Cells displayed cytosolic staining suggesting that there was a pool of recombinant 
proteins in the cytosol. (C, D) Trypanosomes treated with extraction buffer and fixed 
with PFA were labelled with α-GFP and α-PFRA. YFP-Protein 9 appeared to be pre-
sent on the flagellar axoneme (arrows) since the α-GFP signal was found on top of 
the PFR (*) and extended beyond it. Bars, 5µm. 
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3.2.10 Protein 10, Tb927.2.5040 
Tb927.2.5040 is a 19,63kDa protein containing 3 MORN repeats near the C-terminus 
(Fig.3.2.18). 
 
Fig. 3.2.18 Schematic of Protein 10 (Tb927.2.5040). 
By immunofluorescence microscopy, a strong signal from the nucleus was observed 
in PFΑ-fixed cells (Fig.3.2.19 A). With α-GFP antibodies a whole cell labelling pat-
tern was instead observed. This might be due to the fact that α-GFP antibodies also 
recognize unfolded proteins present in the cytosol. After treatment with extraction 
buffer the protein was found on the flagellum (Fig.3.2.19 B). Colabelling with α-
PFRA showed that YFP-Protein 10 was found on top and extended beyond the PFR 
(Fig.3.2.19 C). Therefore Protein 10 probably localizes to the axoneme. 
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Fig. 3.2.19 Trypanosomes 427 cells transiently expressing YFP-Protein 10 
(Tb927.2.5040). 
Cells were fixed with (A) PFA or (B,C) pretreated with extraction buffer and fixed 
with PFA. α-GFP antibodies were used to amplify the YFP signal. Nuclear and kine-
toplast DNA were labelled with DAPI. (A) PFΑ-fixed cells displayed a strong signal 
from the nucleus (arrow) and some cytosolic labelling with α-GFP. (B, C) In deter-
gent-extracted cytoskeletons the fusion protein was found on top of the PFR (*). The 
α-GFP signal further extended beyond the PFR (arrow) towards the kinetoplast. Bars, 
5µm. 
3.2.11 Protein 11, Tb11.01.1460 
The 37kDa protein Tb11.01.1460 contains 6 MORN-repeats (Fig.3.2.20). 
 
Fig. 3.2.20 Schematic of Protein 11 (Tb11.01.1460). 
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YFP-Protein 11 appeared in the cytosol and on a structure next to the kinetoplast 
(Fig.3.2.21A). After extraction the signal was solely found on a punctate structure 
(Fig.3.2.21 B). Costaining with α-TbCen2, which labels the flagellum and the basal 
body, showed that the recombinant protein colocalized with the basal bodies (data 
not shown). The basal body localization was further confirmed by colocalization with 
YL1/2 (Fig.3.2.21 C). 
 
Fig. 3.2.21 Trypanosomes expressing YFP-Protein 11 (Tb11.01.1460). 
Cells were fixed with (A) PFA or (B, C) treated with extraction buffer and fixed with 
PFA. To increase the YFP signal α-GFP antibodies were used. Nuclear and kineto-
plast DNA were labelled with DAPI. (A) In PFΑ-fixed cells the tagged protein ap-
peared in the cytosol and on a structure next the kinetoplast (arrowheads). (B) Cells 
treated with detergent show punctuate labelling (arrowheads) next the kinetoplast. 
(C) This punctuate labelling partially overlapped with the YL1/2 signal (arrowhead). 
Bars, 5µm. 
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3.2.12 Protein 12, Tb927.5.3880 
Amplification of the ORF of Protein12 (Tb927.5.3880) with Vent polymerase did 
not lead to any product. Adjusting PCR conditions and using HiFi Taq polymerase 
finally gave rise to a 2223 base pair long product. The Tb927.5.3880 ORF codes for 
a 83kDa protein which contains 2 MORN-repeats and 8 predicted transmembrane 
regions (Fig.3.2.22). Since this transmembrane protein carries an N-terminal signal 
peptide the YFP tag was placed at the C-terminus. The construct carries one muta-
tion, S580P, which was not found in any domain and therefore I consider it unlikely 
to influence localization. 
 
Fig. 3.2.22 Protein 12 (Tb927.5.3880). 
Transmembrane regions are represented by purple boxes. 
PFΑ-fixed cells displayed a meshed labelling pattern across the whole cell body 
(Fig.3.2.23). This might be mitochondrial labelling. In MeOH- fixed or extracted 
cells no signal was observed (data not shown). 
 
Fig. 3.2.23 Trypanosomes 427 cells expressing Protein 12-YFP (Tb927.5.3880). 
Cells were fixed with PFA and α-GFP antibodies were used to amplify the YFP sig-
nal. Nuclear and kinetoplast DNA were labelled with DAPI. YFP and α-GFP showed 
a meshed labelling pattern across the whole cell body. Bars, 5µm. 
3.2.13 Protein 13, Tb927.7.3400 
Tb927.7.3400 encodes a 49kDa large protein with 11 MORN-repeats (Fig.3.2.24). 
Protein 13 ORF was also amplified by HiFi Taq since Vent polymerase did not lead 
to any product. A C-terminal YFP tag was necessary as this protein has a predicted 
signal peptide at the N-terminus. 
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Fig. 3.2.24 Schematic image of Protein 13 (Tb927.7.3400). 
 
Protein 13-YFP was present in the cytosol in intact cells (Fig.3.2.25 A). This sug-
gested that the recombinant protein was found in a pool of cytosolic proteins. Extrac-
tion further revealed flagellum localization (Fig.3.2.25 B). PFRA costaining indi-
cated that the PFR and the α-GFP staining colocalized (Fig.3.2.25 C). Thus 
Tb927.7.3400 seemed to localize to the PFR. 
 
Fig. 3.2.25 Localization of Tb927.7.3400-YFP. 
Cells were fixed with (A) PFA or (B,C) extracted and fixed with PFA. Nuclear and 
kinetoplast DNA were labelled with DAPI. (A) Uniform cytosolic signal was ob-
served. (B) Trypanosomes displayed flagellum staining. (C) α-PFRA labelling and α-
GFP staining colocalized (arrow). Bars, 5µm. 
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3.2.14 Protein 14, Tb927.1.1910 
Tb927.1.1910 is a 1258 amino acid long, approximately 136kDa protein with 3 
MORN-repeats (Fig.3.2.26). RNAi experiments in bloodstream form Trypanosomes 
had previously shown abnormal cell cycle progression (Subramaniam et al, 2006). 
 
Fig. 3.2.26 Protein 14 (Tb927.1.1910). 
Amplification of the ORF of Protein 14 was first performed with Vent polymerase. 
Despite repeated cloning attempts with two different polymerases (Vent, HiFi Taq) 
amplification of the gene ORF was unsuccessful. 
3.2.15 Protein 15, Tb927.3.4270 
The 100kDa protein Tb927.3.4270 contains 17 MORN repeats (Fig.3.2.27). Amplifi-
cation of protein 15 ORF with Vent polymerase first lead to multiple PCR products. 
Therefore we used a higher annealing temperature of 60°C which resulted in no 
product. Finally HiFi Taq polymerase gave rise to a 2751 base pair long product. 
Sequencing of the selected clone revealed several mutations (S210L, Y268H, S549G, 
M669L, V706A, R761K, E823D, N830S) but all mutations were found in repeated 
PCR. Unfortunately the first and third mutation are found within MORN-repeats. 
Despite big efforts in cloning, and screening of several clones, fewer mutations could 
not be achieved. 
 
Fig. 3.2.27 Schematic of Protein 15 (Tb927.3.4270). 
Transient expression of Protein 15-YFP and PFA fixation of Trypanosomes resulted 
in cytosolic staining by α-GFP antibodies (Fig.3.2.28 A). This showed that the fluo-
rescent protein was expressed and present in the cytosol. MeOH fixation also lead to 
whole cell labelling (Fig.3.2.28 B). After detergent extraction this staining was lost 
and no signal could be detected (data not shown). 
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Fig. 3.2.28 Expression of Protein 15-YFP (Tb927.3.4270) examined by immunof-
luorescence microscopy using α-GFP antibodies. 
Nuclear and kinetoplast DNA were labelled with DAPI. Cytosolic signal and label-
ling were observed in PFΑ-fixed cells (A). Cells after MeOH treatment also showed 
cytosolic labelling pattern (B). Bars, 5µm. 
3.2.16 Protein 16, Tb927.1.740 
Tb927.1.740 ORF codes for a 49kDa protein with 3 MORN-repeats (Fig.3.2.29). 
 
Fig. 3.2.29 Schematic of Protein 16 (Tb927.1.740). 
Immunofluorescence microscopy revealed a cytosolic labelling pattern in YFP-
Protein16 expressing cells (Fig.3.2.30). PFΑ-fixed Trypanosomes additionally show 
signal from a structure next the kinetoplast which according to size and shape might 
come from the basal bodies. In MeOH-fixed and extracted cells fixed with PFA no 
signal could be observed, which implied that the signal was lost after extraction (data 
not shown). 
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Fig. 3.2.30 YFP-Protein 16 (Tb927.1.740) expressing cells were fixed with PFA 
and stained with α-GFP antibodies. 
Nuclear and kinetoplast DNA were labelled with DAPI. A cytosolic labelling pattern 
was observed. Additionally a YFP signal from a structure (arrowhead) next to the 
kinetoplast was seen. Shape and size might indicate basal body localization. Bar, 
5µm. 
3.2.17 Protein 17, Tb927.7.530 
Tb927.7.530 is a protein of 171kDa and contains 21 MORN-repeats and a predicted 
zinc finger motif (Fig.3.2.31). 
 
Fig. 3.2.31 Protein 17 (Tb927.7.530). 
The predicted zinc finger domain is represented by the blue box. 
Cloning of the Tb927.7.530 gene was unsuccessful despite the use of 3 different po-
lymerases (Vent, Taq, PFU Ultra) and multiple optimization attempts. The PCR 
product always displayed several deletions. 
3.2.18 Western blot analysis 
In order to confirm the expression of the YFP-tagged proteins in transfected Try-
panosomes I performed Western blot analysis of whole cell lysates using antibodies 
against GFP (Fig.3.2.32). For 9 recombinant proteins, namely Protein 
1,4,6,7,8,10,11,13 and 15, bands of proper size were detected confirming the expres-
sion of YFP-tagged proteins. Despite experimenting with higher transfer (increased 
current for transfer and longer transfer time) and loading of 1,2x10
7
 cells, no signals 
for Protein 2,3,9,12 and 16 were observed (data not shown). Expression of YFP 
alone would lead to a band at 27kDa. This was not observed. I rather think that YFP-
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tagged proteins were expressed at a lower level and therefore were not detected by 
Western blot. 
 
Fig. 3.2.32 Western blot analysis of whole cell lysates. 
Lysates obtained from cells around 16 hours after transfection with indicated YFP 
constructs. Membranes were probed with antibodies against GFP. 2x10
6
 cells were 
loaded per lane (4x10
6
 for construct 15). 
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3.3 TbMORN1-truncations 
3.3.1 General experimental strategy  
The aim of this project was to identify the targeting sequence of TbMORN1 and de-
fine which of these MORN-repeats are essential and which are dispensable for proper 
targeting. To address these questions TbMORN1 N- and C-terminal truncation con-
structs (Fig.3.3.1 and Table 3.3-1) were N-terminal YFP-tagged and expressed in 
T.brucei 427 cells. Recombinant proteins were screened for bilobe localization by 
immunofluorescence microscopy. Cells and extracted cytoskeletons were fixed with 
PFA. α-GFP antibodies were used to enhance the YFP signal. Costaining with anti-
bodies against marker proteins, as for the MORN-repeat protein family experiments, 
were performed if necessary. Localization was also investigated by biochemical frac-
tionation of transfected cells. Equal fractions of input, cytoplasmic supernatant and 
cytoskeletal pellet were analyzed by Western blotting using α-GFP antibodies. For 
detection of endogenous TbMORN1 α-MORN1 antibodies were used. 
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Fig. 3.3.1 Truncation constructs 
 
 
construct AA MORN-repeats 
TbMORN1 1-358 1-15 
TbMORN1(72-358) 72-358 4-15 
TbMORN1(146-358) 146-358 7-15 
TbMORN1(215-358) 215-358 10-15 
TbMORN1(284-358) 284-358 13-15 
TbMORN1(330-358) 330-358 15 
TbMORN1(1-353) 1-353 1-15 
TbMORN1(1-350) 1-350 1-14 
TbMORN1(1-343) 1-343 1-14 
TbMORN1(1-336) 1-336 1-14 
TbMORN1(1-329) 1-329 1-14 
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TbMORN1(1-320) 1-320 1-13 
TbMORN1(1-312) 1-312 1-13 
TbMORN1(1-260) 1-260 1-10 
TbMORN1(1-145) 1-145 1-6 
TbMORN1(146-343) 146-343 7-14 
TbMORN1(146-329) 146-329 7-14 
Table 3.3-1 TbMORN1 truncation constructs 
 
3.3.2 TbMORN1 
Screening of full length TbMORN1(1-358) by immunofluorescence microscopy 
showed a hook-shaped structure next the kinetoplast in PFA-fixed cells. For 2K1N 
cells two of these structures were observed (Fig.3.3.2 A). Additionaly “spear” shaped 
structures of constant width but varying length were observed (Fig.3.3.2 B). This 
artefactual paracrystalline structure was previously observed for YFP-tagged 
TbMORN1 (Morriswood et al., 2009). “Spear” formation was observed in 44% of 
transfected cells fixed with PFA (data not shown). α-GFP antibodies further 
recognize a pool of recombinant proteins in the cytosol visible by whole cell 
labelling (Fig.3.3.2 A). This indicates that the YFP-tagged protein is expressed and 
present in the cytosol but might also be due to the detection of unfolded tagged 
protein. Detergent-extracted cytoskeletons showed localization of the YFP fusion 
proteins at the bilobe (Fig.3.3.2 C) which was confirmed by colocalization with 
TbLRRP1 in single 0.1µm sections (Fig.3.3.2 D). 
Immunoblotting of fractionated cell lysates with α-GFP antibodies detected an 
approximatly 67kDa protein which confirmed the expression of YFP-TbMORN1(1-
358) observed by IF. The YFP-tagged protein was present in all three fractions but a 
stronger signal from the cytoskeletal fraction than from the cytoplasmic sample was 
observed (Fig.3.3.3 A). This indicated that YFP-TbMORN1 preferentialy associates 
with the cytoskeletion. α-MORN1 antibodies detected endogenous TbMORN1 at 
41kDa which was targeted to the cytoskeletal fraction (Fig.3.3.3 B). Comparing 
YFP-TbMORN1 and endogenous TbMORN1, a strong signal for cytoskeletal 
fractions was observed for both. YFP-TbMORN1 is also found in the supernatant 
fraction whereas endogenous TbMORN1 is soley in the pellet fraction. This indicates 
that more of the YFP-tagged version is found in the cytosol compared to the 
endogenous but overall YFP-tagged proteins are a good model for studing targeting 
of TbMORN1. 
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Fig. 3.3.2 Localization of YFP-tagged TbMORN1(1-358). 
Transiently transfected procyclic cells were fixed with PFA; α-GFP antibodies were 
used to enhance the YFP signal (A). PFΑ-fixed cells showed a hook shaped structure 
(arrow) next to the kinetoplast and some cytosolic labelling. (B) Additionally artifac-
tual “spear”-shaped structures (*) were observed. (C, D) T. brucei cells were treated 
with detergent and the extracted cytoskeletons were fixed with PFA (C). Localization 
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of the YFP fusion protein at a bilobe shaped structure (arrow) was also observed un-
der these conditions. (D) Colocalization with TbLRRP1 in single sections showed 
localization of YFP-TbMORN1 at the bilobe (arrow). Nuclear and kinetoplast DNA 
were in all cases labelled with DAPI. Bars, 5µm. 
 
 
Fig. 3.3.3 Fractionation of YFP-
TbMORN1-transfected cells. 
Procyclic cells transiently expressing YFP-
TbMORN1 were treated with detergent to 
solubilise cytoplasmic and membrane-
associated proteins, and the fractions sepa-
rated by centrifugation. Equal fractions of 
Input (I), soluble supernatant (SN) and in-
soluble pellet (P) were separated by SDS-
PAGE and analyzed by western blotting. 
(A) Samples probed with α-GFP antibodies. 
The predicted MW of YFP-TbMORN1 is 
approximately 67 kDa. (B) Samples probed 
with α-MORN1 antibodies. Endogenous 
TbMORN1 is 40 kDa. Lanes contain a 1% 
fraction of each sample. 
 
 
3.4 N-terminal truncations 
3.4.1 TbMORN1(72-358) 
This truncated construct was missing the first 213 base pairs coding for 71 amino 
acids and contains the last 12 MORN repeats (4-15). Sequencing revealed that this 
construct carries a mutation Y215C which was found in the original template con-
struct and was shown not to affect proper localization at the bilobe (B. Morriswood, 
personal communication). 
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T.brucei 427 cells were used to transiently express the truncated construct. In PFA 
fixed cells the fusion protein was present in the cytosol and on a hook-shaped struc-
ture next to the kinetoplast (Fig.3.4.1 A). For MeOH fixation faint cytosolic labelling 
was observed (data not shown). In detergent extracted cytoskeletons YFP-
MORN1(72-358) localized to the bilobe observable by YFP and α-GFP labelling 
(Fig.3.4.1 B) . Colocalization with TbLRRP1 confirmed that the truncated protein 
proper targeted to the bilobe (Fig.3.4.1 C). 
Western blot analysis revealed that the YFP-tagged protein was found in the input, 
the supernatant and also the pellet fraction (Fig.3.4.2 A). Compared to the full-length 
TbMORN1 (Fig.3.3.3 A) less tagged protein was found in the pellet and more in the 
supernatant. The latter indicates that the truncated version is more present in the cy-
tosol. 
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Fig. 3.4.1 Localization of YFP-TbMORN1(72-358). 
Procyclic cells were fixed with PFA (A) or extracted with detergent and fixed with 
PFA (B, C) and analyzed by immunofluorescence microscopy. YFP-TbMORN1(72-
358) was present in the cytosol and on a hook-shaped structure (arrow) near the kine-
toplast (A). The labelling was preserved in detergent-extracted cytoskeletons (arrow) 
(B). Colocalization with TbLRRP1 confirmed the presence of YFP-TbMORN1(72-
358) at the bilobe (arrow) (C). Nuclear and kinetoplast DNA were in all cases la-
belled with DAPI. Images are representative of 2 independent transfections. Bars, 
5µm. 
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Fig. 3.4.2 Fractionation of cell lysates obtained af-
ter transfection of YFP-TbMORN1(72-358). 
Procyclic cells transiently expressing YFP-
TbMORN1(72-358) were treated with detergent and 
soluble and insoluble fractions were separated by cen-
trifugation. Equal fractions of input (I), soluble super-
nant (SN) and insoluble pellet (P) were analyzed by 
SDS-PAGE and Western blotting. A-GFP antibodies 
recognize a 59kDa protein. Lanes contain 1% fraction 
of each sample. 
3.4.2 TbMORN1(146-358) 
Transient transfection of YFP-TbMORN1(146-358) showed cytosolic labelling and 
two structures near the kinetoplast in PFΑ-fixed cells. The shape and size of these 
structures were reminiscent of the basal bodies and the bilobe (Fig.3.4.3 A). 
Interestingly the punctated structure colocalized with YL1/2 staining indicating that 
the truncated protein was present at the basal bodies (Fig.3.4.3 B). In detergent 
extracted cytoskeletons the signal from the basal bodies was lost and the YFP-tagged 
protein localized only to the bilobe-shaped structure (Fig.3.4.3 C). Costaining with α-
LRRP1 confirmed the presence of YFP-TbMORN1(146-358) at the bilobe (Fig.3.4.3 
D). 
After biochemical fractionation, the 24kDa protein was found in the soluble 
supernatant fraction and only very little was present in the insoluble pellet fraction 
(Fig.3.4.4 A). α-MORN1 antibodies showed that the postive control, the endogenous 
TbMORN1, was present in the cytoskeletal fraction but not the supernatant (Fig.3.4.4 
B). 
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Fig. 3.4.3 Localization of YFP-TbMORN1(146-358). 
Procyclic cells transiently expressing YFP-TbMORN1(146-358) were fixed with 
PFA and analyzed by immunofluorescence microscopy (A). The YFP-tagged protein 
was present in the cytoplasm as well as localizing to two structures near the kineto-
plast. The shape and size of these structures were reminiscent of the basal bodies 
(arrowhead) and the bilobe (arrow). (B) The presence of the construct at the basal 
bodies was confirmed by colocalization with YL1/2 labelling (arrowhead). (C) De-
tergent-extracted cytoskeletons were fixed with PFA and examined by immunofuo-
rescence microscopy. Under these conditions, the signal from the basal bodies was 
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lost and localization only to the bilobed structure (arrows) was observed. (D) This 
structure was confirmed to be the bilobe by colocalization with TbLRRP1 (arrows). 
Bilobe of an untransfected cell (*). Nuclear and kinetoplast DNA were in all cases 
labelled with DAPI. Images are representative of 2 independent transfections. Bars, 
5µm. 
 
 
Fig. 3.4.4 YFP-TbMORN1(146-358)-
expressing cells were fractionated and 
examined by Western blot analysis. 
Fractions of cell lysates were obtained by 
detergent extraction and centrifugation. 
Equal fractions of input (I), soluble superna-
tant (SN) and insoluble pellet (P) were sepa-
rated by SDS-PAGE and membranes were 
treated with α-GFP (A) and α-MORN1 (B) 
antibodies. (A) YFP-TbMORN1(146-358) 
has a predicted MW of 51kDa. (B) Samples 
probed with α-MORN1 recognize endogen-
ous TbMORN1, 40kDa. Lanes contain a 1% 
fraction of each sample. 
 
 
3.4.3 TbMORN1(215-358) 
Immunofluorescence microscopy of YFP-MORN1(215-358) transfected cells re-
vealed whole cell labelling of a cytosolic pool of fusion protein (Fig.3.4.5 Α). The 
YFP-tagged protein furthermore localized to two structures near the kinetoplast 
(Fig.3.4.5 A). One was basal body localization as it was shown by overlap with 
YL1/2 (Fig.3.4.5 B) The second structure was the bilobe, as confirmed by colocaliz-
ing with α-LRRP1 antibodies (Fig.3.4.5 C). 
Expression of the YFP-tagged protein was confirmed by western blot analysis as the 
α-GFP antibodies detected an approximately 43kDa protein. This band was present 
in all three fractions which proves that the truncated protein was targeted to the cy-
toskeleton (Fig.3.4.6). 
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Fig. 3.4.5 Localization of YFP-TbMORN1(215-358). 
Procyclic cells expressing YFP-TbMORN1(215-358) showed cytosolic labelling 
with α-GFP antibodies after PFA fixation. Furthermore labelling of two structures 
near the kinetoplast reminiscent of the basal body (arrowheads) and bilobe (arrows) 
was observed in PFΑ-fixed cells (A). The presence of YFP-TbMORN1(215-358) at 
the basal body (arrowhead) was confirmed using costaining with YL1/2 antibodies 
(B). Detergent-extracted cells were fixed with PFA and stained with α-LRRP1 and α-
GFP antibodies. YFP-TbMORN1(215-358) colocalized with TbLRRP1 (arrows) (C). 
Nuclear and kinetoplast DNA were in all cases labelled with DAPI. Images are rep-
resentative of 2 independent transfections. Bars, 5µm. 
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Fig. 3.4.6 Western blot analysis of frac-
tionated YFP-TbMORN1(215-358)-
transfected cell lysates. 
Procyclic cells were transfected with YFP-
TbMORN1(215-358) and lysates extracted 
with detergent and separated by centrifuga-
tion. This resulted in three fractions input 
(I), soluble supernatant (SN) and insoluble 
pellet (P). Equal fractions were examined by 
SDS-PAGE and Western blotting. Samples 
probed with α-GFP. The truncated protein is 
43kDa. Lanes contain a 1% fraction of each 
sample. 
 
 
3.4.4 TbMORN1(284-358) 
Observation of T.brucei 427 cells transfected with YFP-TbMORN1(284-358) and 
fixed with PFA showed that the protein was present in the cytosol (Fig.3.4.7 A) and 
additionally on a structure next the kinetoplast which overlaps with YL1/2 labelling 
(Fig.3.4.7 B). In contrast to other constructs no signal from the bilobe was observed 
in PFA or Xtr+PFA fixed cells (data not shown). This suggested that the truncated 
protein was no longer targeted to the bilobe. 
Western blot of fractionated cell lysates showed that YFP-TbMORN1(284-358) was 
expressed and present in the input, the supernatant and very little in the pellet frac-
tion. This means that the tagged protein mainly targeted to the cytoplasm and that 
very little was present at the cytoskeleton (Fig.3.4.8 A). Using α-MORN1 antibodies 
the endogenous TbMORN1 protein, 40kDa, was recognized. As expected this pro-
tein was found in the cytoskeletal but not cytoplasmic fraction (Fig.3.4.8 B). 
As previously observed the signal from the bilobe got weaker after extraction, espe-
cially if few cells were transfected there is a chance to miss the signal. In order to 
make sure that YFP-TbMORN1(284-358) did not target to the bilobe and that we 
might not see the signal we tried to create a stable cell line. Unfortunately after two 
rounds of transfection and plating the only clone obtained was positive for presence 
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of the blasticidin gene but negative for the YFP construct. This implies that cells 
must have picked up the selection gene but not the YFP construct. 
 
Fig. 3.4.7 Localization of YFP-TbMORN1(284-358). 
The YFP tagged protein was present in the cytosol (A) as well as on a structure (ar-
rowheads) next to the kinetoplast which colocalized with YL1/2 labelling (arrow-
head) (B). α-GFP antibodies showed cytosolic labelling. Nuclear and kinetoplast 
DNA were labelled with DAPI. Images are representative of 3 independent transfec-
tions. Bars, 5µm. 
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Fig. 3.4.8 Fractionation of YFP-
TbMORN1(284-358)-expressing cells. 
Procyclic cells transiently expressing YFP-
TbMORN1(284-358) were treated with 
extraction buffer and separated into soluble 
and insoluble fractions by centrifugation. 
Equal fractions of input (I), supernatant 
(SN) and pellet (P) were examined by SDS-
PAGE and Western blotting. (A) α-GFP 
antibodies recognize the 38kDa YFP-tagged 
protein. (B) Membrane treated with α-
MORN1 antibodies showed the 40kDa en-
dogenous TbMORN1. Lanes contain a 1% 
fraction of each sample. 
 
 
3.4.5 TbMORN1(330-358) 
Immunofluorescence microscopy reveals that the fluorescent protein was present in 
the cytosol and on a structure next the kinetoplast (Fig.3.4.9). The shape and size of 
this structure are reminiscent of basal body localization. 
Fig. 3.4.9 Localization of YFP-TbMORN1(330-358). 
Procyclic cells were fixed with PFA and labelled with α-GFP antibodies. Expression 
of the YFP-tagged protein in the cytoplasm as well as its localization to a structure 
(arrowhead) next the kinetoplast was observed. Nuclear and kinetoplast DNA were 
labelled with DAPI. Bar, 5µm. 
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The 30kDa protein was present in the input and the supernatant fraction but absent in 
the pellet fraction as it was shown by Western blot analysis (Fig.3.4.10 A). Figure 
3.4.10 B shows the positive control endogenous TbMORN1. 
 
 
Fig. 3.4.10 Analysis of fractionated cell 
lysates after expression of YFP-
TbMORN1(330-358). 
Procyclic cells transiently expressing YFP-
TbMORN1(330-358) were treated with 
detergent and the lysates separated by cen-
trifugation. Input (I), supernatant (SN) and 
pellet (P) samples were loaded in equal 
fractions on polyacrylamide gels and sepa-
rated by SDS-PAGE. Western blotting with 
α-GFP antibodies showed the 30kDa YFP-
tagged protein (A). (B) Endogenous 
TbMORN1, 40kDa, was recognized by α-
TbMORN1 antibodies. Lanes contain a 1% 
fraction of each sample. 
 
 
3.5 C-terminal truncations 
3.5.1 TbMORN1(1-353) 
PFA fixation of YFP-TbMORN1(1-353) transfected cells showed some nuclear la-
belling and a very faint bilobe-shaped structure (Fig.3.5.1 A). This structure over-
laped with α-LRRP1 labelling (Fig.3.5.1 B). Therefore this truncated construct was 
present at the bilobe although it seemed to be expressed at a lower level than other 
constructs. This might also be an explanation why spear formation was not observed. 
On Western blot no expression of YFP-TbMORN1(1-353) could be detected despite 
multiple attempts (data not shown). 
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Fig. 3.5.1 Localization of YFP-TbMORN1(1-353). 
Immunofluorescence microscopy images of procyclic cells transiently expressing 
YFP-TbMORN1(1-353). In PFΑ-fixed Trypanosomes nuclear labelling (arrowhead) 
and a very faint signal from a bilobe-shaped structure (arrow) were observed (A). In 
detergent extracted cells fixed with PFA, α-GFP antibodies recognized a hook-
shaped structure which colocalized with α-LRRP1 labelling (arrows) (B). Nuclear 
and kinetoplast DNA were in all cases labelled with DAPI. Bars, 5µm. 
 
3.5.2 TbMORN1(1-350) 
Trypanosomes transiently expressing YFP-TbMORN1(1-350) were fixed with PFA 
and MeOH (data not shown). The truncated protein was observed in the cytosol and 
on the basal body and the bilobe (Fig.3.5.2 A). Additionally the YFP protein was 
present on a spear shaped structure of fixed width but random length (Fig.3.5.2 A 
and B). This paracrystalline structure was artefactual and was also observed for the 
full length TbMORN1. For PFΑ-fixed cells this spear formation was detected in 53% 
of cells (data not shown). Upon MeOH fixation or extraction and PFA fixation the 
recombinant protein was only present at the bilobe (Fig.3.5.2 C). This localization 
was confirmed by costaining with α-LRRP1 (Fig.3.5.2 D). 
The 66kDa protein was recognized by α-GFP antibodies on Western blot analysis. 
The protein was present in all three fraction (Fig.3.5.3). 
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YFP-TbMORN1(1-350) localized to the basal bodies and the bilobe as it was shown 
by fluorescence microscopy. Fractionation backed up this idea since the YFP tagged 
protein was present in cytoplasmic as well as in cytoskeletal fraction. 
 
Fig. 3.5.2 Localization of YFP-TbMORN1(1-350). 
Procyclic cells fixed with PFA and treated with α-GFP antibodies were examined by 
immunofluorescence microscopy. Upon PFA fixation YFP signal was observed in 
  88 
the cytosol and on two structures near the kinetoplast, suggesting basal body (arrow-
head) and bilobe (arrow) labelling (A). Colocalization with YL1/2 confirmed that the 
construct was at the basal bodies (arrowhead) (B). Additionally YFP was present on 
a “spear” shaped structure (*). Transfected cells were extracted with 0.5% NP40 and 
fixed with PFA (C,D). Α-GFP antibodies recognized a hook shaped structure (ar-
rows) (C) which colocalized with α-LRRP1 labelling (arrows) (D). Bilobe of an un-
transfected cell (**). Nuclear and kinetoplast DNA were in all cases labelled with 
DAPI. Images are representative of 2 independent transfections. Bars, 5µm. 
 
 
Fig. 3.5.3 Fractionated cell lysates of 
YFP-TbMORN1(1-350) transfected cells. 
Input (I), supernatant (SN) and pellet (P) 
samples were obtained after detergent ex-
traction and centrifugation of YFP-
TbMORN1(1-350) expressing cells. Equal 
fractions were examined by SDS-PAGE and 
Western blotting. (A) Α-GFP antibodies 
recognize the 66kDa YFP-tagged protein. 
Lanes contain a 1% fraction of each sample. 
 
 
3.5.3 TbMORN1(1-343) 
Immunofluorescence microscopy of YFP-TbMORN1(1-343) transfected cells 
showed cytosolic labelling by α-GFP antibodies. The YFP construct was also found 
at two structures near the kinetoplast suggesting basal body and bilobe localization 
(Fig.3.5.4 A). By costaining with YL1/2 antibodies the basal body localization could 
be confirmed (Fig.3.5.4 B). In detergent extracted cytoskeletons in contrast no signal 
from the bilobe could be observed (data not shown). 
After transfection with YFP-TbMORN1(1-343) fractionated cell lysates were ob-
tained for western blot analysis. α-GFP antibodies recognized an approximately 
66kDa protein in the input and cytoplasmic samples (Fig.3.5.5 A). This suggested 
that the YFP tagged protein stayed in the cytosol and was not transported to the cy-
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toskeleton. The endogenous TbMORN1, recognized by α-MORN1 antibodies, in 
contrast was targeted to the cytoskeletal fraction (Fig.3.5.5 B). 
 
 
Fig. 3.5.4 Localization of YFP-TbMORN1(1-343). 
The YFP-tagged protein was present in the cytosol as well as on 2 structures near the 
kinetoplast. Size and shape suggested basal bodies (arrowhead) and bilobe (arrow) 
labelling (A). Colocalization with YL1/2 antibodies confirmed presence of YFP-
TbMORN1(1-343) at the basal bodies (arrowhead) (B). Transiently transfected cells 
were fixed with PFA. Nuclear and kinetoplast DNA were labelled with DAPI. Im-
ages are representative for 2 independent transfections. Bars, 5µm. 
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Fig. 3.5.5 Fractionated cell lysates of 
YFP-TbMORN1(1-343) transfected cells. 
In order to solubilise cytoplasmic and mem-
brane-associated proteins YFP-
TbMORN1(1-343)-transfected cells were 
treated with extraction buffer. Centrifuga-
tion of lysates then lead to three fractions: 
input (I), supernatant (SN) containing so-
luble proteins and pellet (P) containing inso-
luble proteins. Equal fractions were ana-
lyzed by SDS-PAGE and Western blotting. 
(A) Samples probed with α-GFP. The re-
combinant protein is 66kDa. (B) The mem-
brane was treated with α-TbMORN1 anti-
bodies. Endogenous TbMORN1 is 40kDa. 
Lanes contain a 1% fraction of each sample. 
 
 
3.5.4 TbMORN1(1-336) 
Trypanosomes transfected with YFP-TbMORN1(1-336) and fixed with PFA showed 
a cytosolic labelling and also on a structure next to the kinetoplast (Fig.3.5.6 A). By 
using YL1/2 antibodies its localization at the basal bodies was confirmed (Fig.3.5.6 
B). Detergent extracted cytoskeletons revealed that the truncated protein was present 
at the bilobe and colocalized with α-LRRP1 antibodies (Fig.3.5.6 C). 
The 38kDa protein was present in all three fractions, with less in the cytoskeletal 
sample (Fig.3.5.7). This showed that the fusion protein mainly stays in the cytosol 
and that little was targeted to cytoskeletal proteins. 
Immunofluorescence microscopy images showed that the YFP-TbMORN1(1-336) 
construct was present in the cytosol, at the basal bodies and at the bilobe. By Western 
blotting it was shown that the tagged protein was targeted to both fractions but 
mainly to the cytoplasmic fraction. 
  91 
 
Fig. 3.5.6 Localization of YFP-TbMORN1(1-336). 
(A) Procyclic Trypanosomes were transiently transfected, fixed with PFA, and la-
belled with antibodies against GFP. The YFP signal revealed cytosolic labelling and 
some additional signals which might come from the basal bodies (arrowheads) and 
the bilobe (arrows). α-GFP antibodies showed uniform cytosolic staining. (B) Using 
YL1/2 antibodies colocalization of YFP-tagged protein with the basal bodies (arrow-
heads) was observed. (C) In detergent extracted cytoskeletons the structure recog-
nized by α-GFP antibodies colocalized with α-LRRP1 labelling (arrows). Nuclear 
and kinetoplast DNA were in all cases labelled with DAPI. Images are representative 
of 2 independent transfections. Bars, 5µm. 
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Fig. 3.5.7 YFP-TbMORN1(1-336) frac-
tionated cell lysates. 
Trypanosomes transiently expressing YFP-
TbMORN1(1-336) were treated with extrac-
tion buffer to solubilise cytoplasmic and 
membrane associated proteins. Samples of 
input (I), supernatant (SN) representing the 
cytoplasmic fraction and pellet (P) 
representing the cytoskeletal proteins were 
loaded in equal fractions on a gel. After 
SDS-PAGE proteins were transferred onto a 
nitrocellulose membrane and analyzed by 
Western blotting. Membrane treated with 
antibodies against GFP. The YFP-tagged 
protein is 65 kDa. Lanes contain a 1% frac-
tion of each sample. 
 
 
3.5.5 TbMORN1(1-329) 
In transient transfection experiments YFP-TbMORN1(1-329) localized to the cyto-
sol, to the basal body, and some structure near the kinetoplast (Fig.3.5.8 A). Basal 
body localization was confirmed by colocalization with YL1/2 (Fig.3.5.8 B). Surpris-
ingly no signal from any of these structures was observed in detergent extracted cells 
(data not shown). 
Fractionated cell lysates analyzed by Western blot showed that the recombinant pro-
tein was expressed and present in all three fractions (Fig.3.5.9). So according to blot-
ting the protein was targeted to the cytoplasm and the cytoskeleton. 
Since there was a chance of missing bilobe labelling after extraction and to correct 
for low transfection efficiency we created a stable cells line with YFP-TbMORN1(1-
329). Unfortunately the one clone obtained did not express the YFP-tagged protein as 
determined by immunofuorescence and western blotting. Again the PCR for the blas-
ticidin resistance gene was positive which implies that cells had acquired that but not 
the target DNA. 
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Fig. 3.5.8 Localization of YFP-TbMORN1(1-329). 
Procyclic Trypanosomes were fixed with PFA, and α-GFP antibodies were used to 
enhance the YFP signal. (A) Α-GFP antibodies showed cytosolic staining. The YFP-
tagged protein localized to the cytoplasm and a structure (arrow) near the kinetoplast 
and a structure (arrowhead) which overlapped with YL1/2 antibodies (arrowheads) 
(B). Nuclear and kinetoplast DNA were in all cases labelled with DAPI. Im-
munofluorescence microscopy images are representative of 3 independent transfec-
tions. Bars, 5µm. 
 
 
 
Fig. 3.5.9 Fractionation of YFP-
TbMORN1(1-329)-expressing cells. 
Procyclic cells were transiently transfected 
with YFP-TbMORN1(1-329). Cell fractions 
were obtained by centrifugation after treat-
ment with detergent. Fractions of input (I), 
soluble proteins present in the supernatant 
(SN) and insoluble proteins in the pellet (P) 
were loaded in equal amounts for SDS-
PAGE. Immunoblotting was performed with 
α-GFP antibodies. The truncated protein, 64 
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kDa, was expressed. Lanes contain a 1% 
fraction of each sample. 
 
 
3.5.6 TbMORN1(1-320) 
After fixation with PFA the tagged protein was observed in the cytosol and at two 
structures (Fig.3.5.10 A). YL1/2 treatment showed that the signal next to the kineto-
plast came from the basal bodies (Fig.3.5.10 B). The second, fork-shaped structure 
was the bilobe as shown by costaining with α-LRRP1 antibodies (Fig.3.5.10 C). In 
MeOH-fixed cells no signal could be detected (data not shown). 
 
Fig. 3.5.10 Localization of YFP-TbMORN1(1-320). 
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Procyclic Trypanosomes were stained with α-GFP antibodies (A) or YL1/2 antibod-
ies (B) after fixation with PFA. For the YFP-tagged protein cytosolic labelling and 
additionally two structures (arrows and arrowheads) near the kinetoplast were ob-
served. Merged pictures with YL1/2 showed that one of these structures represented 
the basal bodies (arrowheads). (C) Detergent extracted cytoskeletons revealed local-
ization of YFP-TbMORN1(1-320) at the bilobe (arrow) which was confirmed by 
colocalization with α-LRRP1 labelling. Nuclear and kinetoplast DNA were in all 
cases labelled with DAPI. Images represent data from two independent transfections. 
Bars, 5µm. 
Western blot analysis revealed that the fusion protein, 63kDa, was expressed and 
present in the input, the cytoplasmic and very little in the cytoskeletal fraction 
(Fig.3.5.11 A). The endogenous TbMORN1 in contrast was found in the input and in 
the pellet fraction (Fig.3.5.11 B). 
 
 
Fig. 3.5.11 Western blot analysis of frac-
tionated cell lysates obtained after trans-
fection with YFP-TbMORN1(1-320). 
Fractionated lysates were obtained by cen-
trifugation after extraction with detergent. 
Equal fractions of input (I), soluble superna-
tant (SN) and insoluble pellet (P) were ana-
lyzed by SDS-PAGE and Western blotting. 
(A) α-GFP antibodies recognized a 63kDa 
band which confirmed the expression of the 
YFP-tagged protein. (B) The endogenous 
TbMORN1, 40kDa, was recognized by α-
TbMORN1 antibodies. Lanes contain a 1% 
fraction of each sample. 
 
 
3.5.7 TbMORN1(1-312) 
YFP-TbMORN1(1-312) localized to the bilobe. The protein was found in the 
cytosol, at the basal bodies, and at the bilobe (Fig.3.5.12 A). These localizations were 
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confirmed by costaining with YL1/2 (Fig.3.5.12 B) and TbLRRP1 (Fig.3.5.12 C). In 
MeOH fixed cells no signal was detected (data not shown). 
The 63kDa protein was found in the input, cytoplasmic and very little in the 
cytskeletal fraction (Fig.3.5.13 A). Therefore the YFP tagged protein mainly stayed 
in the cytosol. Additionaly we performed Western blot analysis with α-MORN1 
antibodies which revealed that the endogenous MORN1 was present in the input and 
the pellet fraction (Fig.3.5.13 B). 
 
 
Fig. 3.5.12 Localization of YFP-TbMORN1(1-312). 
(A) Procyclic Trypanosomes expressing YFP-TbMORN1(1-312) were fixed with 
PFA and stained with α-GFP antibodies. The YFP-tagged protein was found in the 
cytosol and at two structures near the kinetoplast reminiscent of basal body (arrow-
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head) and bilobe (arrow) labelling. α-GFP showed cytoplasmic staining. (B) Costain-
ing with YL1/2 revealed that the punctate structure next to the kinetoplast (arrow-
heads) was the basal body. (C) Cells treated with extraction buffer and fixed with 
PFA showed colocalization of YFP-MORN1(1-312) with α-LRRP1 labelling (ar-
rows). Nuclear and kinetoplast DNA were in all cases labelled with DAPI. Images 
are representative of 2 independent transfections. Bars, 5µm. 
 
 
 
 
Fig. 3.5.13 Immunoblotting of YFP-
TbMORN1(1-312)- transfected cells. 
Fractionated cell lysates were obtained by 
centrifugation after solubilization of cytop-
lasmic and membrane-associated proteins. 
Three fractions- input (I), supernatant (SN) 
containing cytoplasmic proteins, and pellet 
(P) containing cytoskeletal proteins were 
loaded in equal fractions for SDS-PAGE. 
Western blotting with α-GFP (A) and α-
MORN1 (B) antibodies was performed. (A) 
The expected size of the truncated protein is 
63kDa. (B) The endogenous MORN1 pro-
tein, 40kDa, appears after treatment with α-
MORN1 antibodies. Lanes contain a 1% 
fraction of each sample. 
 
 
3.5.8 TbMORN1(1-260) 
YFP-TbMORN1(1-260) was present in the cytosol and on two faint structures next 
to the kinetoplast (Fig.3.5.14 A). Costaining with YL1/2 confirmed that one of these 
structures was the basal body (Fig.3.5.14 B). MeOH-fixed cells showed uniform cy-
tosolic labelling which might be due to the detection of a cytosolic pool of recombi-
nant protein (data not shown). In detergent extracted cytoskeletons the YFP-tagged 
protein was observed at the bilobe and colocalized with α-LRRP1 labelling 
(Fig.3.5.14 C). 
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Expression of the YFP-tagged protein was confirmed by Western blot analysis where 
α-GFP antibodies detected a 56kDa large protein (Fig.3.5.15 A). Furthermore the 
fusion protein mainly stays in the cytoplasm and only very little was targeted to the 
cytoskeleton as was shown by the fractionation experiment. The endogenous 
MORN1 recognized by α-MORN1 antibodies targeted to the cytoskeleton (Fig.3.5.15 
B). 
 
Fig. 3.5.14 Localization of YFP-TbMORN1(1-260). 
Procyclic cells were fixed with PFA and treated with α-GFP antibodies to increase 
the YFP signal. (A, B) Upon PFA fixation the cells showed cytosolic labelling and 
additionally some faint structures next to the kinetoplast (arrowhead) (A). This struc-
ture colocalized with the basal body marker YL1/2 (arrowheads) (B). (C) In deter-
gent extracted cytoskeletons YFP-TbMORN1(1-260) targeted to the bilobe (arrows) 
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as confirmed by colocalization with TbLRRP1. Nuclear and kinetoplast DNA were 
in all cases labelled with DAPI. Bars, 5µm. 
 
 
 
 
Fig. 3.5.15 Fractionation of YFP-
TbMORN1(1-260)-transfected cells. 
Procyclic cells transiently expressing YFP-
TbMORN1(1-260) were treated with extrac-
tion buffer and fractions separated by centri-
fugation. Input (I) soluble supernatant (SN) 
and insoluble (P) proteins were analyzed by 
SDS-PAGE and Western blotting. (A) 
Membranes treated with α-GFP antibodies 
confirmed the expression of the 56kDa large 
protein. (B) Samples probed with α-
MORN1 antibodies. These recognized the 
endogenous TbMORN1, 40kDa. Lanes con-
tain a 1% fraction of each sample. 
 
 
3.5.9 TbMORN1(1-145) 
YFP-TbMORN1(1-145) showed cytosolic staining (Fig.3.5.16). After extraction with 
detergent no signal was monitored (data not shown). 
Western blot of fractionated cell lysates confirmed that YFP-TbMORN1(1-145) was 
expressed and present in the input and the cytoplasmic fraction (Fig.3.5.17 A). As 
expected there was no signal obtained from the cytoskleletal fraction. α-MORN1 
antibodies further revealed that the endogenous TbMORN1 protein targeted to the 
cytoskeleton (Fig.3.5.17 B). 
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Fig. 3.5.16 Localization of YFP-TbMORN1(1-145). 
Procyclic Trypanosomes transiently expressing YFP-TbMORN1(1-145) were fixed 
with PFA. Immunofluorescence images showed cytosolic staining with α-GFP anti-
bodies. Nuclear and kinetoplast DNA were labelled with DAPI. Data was representa-
tive of 2 independent transfections. Bars, 5µm.  
 
 
Fig. 3.5.17 Immunoblotting of YFP-
TbMORN1(1-145) transfected cell ly-
sates. 
Procyclic 427 cells were transfected with 
YFP-TbMORN1(1-145). Fractionated cell 
lysates were obtained by extracting with 
0.5% NP40 followed by centrifugation. The 
input (I), supernatant (SN) and pellet (P) 
fractions were examined by SDS-PAGE and 
Western blotting. (A) An approximately 
45kDa large protein was detected by α-GFP 
antibodies. (B) Samples probed with α-
TbMORN1. The endogenous TbMORN1, 
40kDa, was recognized. Lanes contain a 1% 
fraction of each sample. 
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3.6 Truncations from both ends 
3.6.1 TbMORN1(146-343) 
Sequencing revealed that this clone carried two mutations, the Y215C as expected 
and in addition A279T. 
Immunofluorescence microscopy of YFP-TbMORN1(146-343) transfected cells 
showed cytosolic labelling with α-GFP antibodies (Fig.3.6.1). After detergent extrac-
tion no signal from any structure could be observed (data not shown). 
α-GFP antibodies recognized a faint signal at approximately 50kDa in all fractions 
(Fig.3.6.2). 
 
Fig. 3.6.1 Localization of YFP-TbMORN1(146-343). 
Transfected cells showed whole cell labelling with α-GFP suggesting that antibodies 
recognized a pool of recombinant protein in the cytosol. Nuclear and kinetoplast 
DNA were labelled with DAPI. Bars, 5µm. 
 
 
Fig. 3.6.2 Western blot analysis of frac-
tionated cell lysates. 
Lysates were obtained from YFP-
TbMORN1(146-343) transfected cells. The 
input (I), the soluble supernatant (SN) and 
the insoluble pellet (P) were analyzed by 
SDS-PAGE and Western blotting. Samples 
probed with α-GFP. The expected protein is 
approximately 50kDa. 
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3.6.2 TbMORN1(146-329) 
YFP-TbMORN1(146-329) showed cytosolic labelling (Fig.3.6.3). After detergent 
extraction no signal from any structure could be detected (data not shown). 
The truncated protein was found in all three fractions as it was shown by Western 
blot analysis (Fig.3.6.4). 
 
Fig. 3.6.3 Localization of YFP-TbMORN1(146-329). 
α-GFP antibodies were used to boost the YFP signal. Both YFP and α-GFP staining 
showed cytosolic labelling. Nuclear and kinetoplast DNA were labelled with DAPI. 
Bars, 5µm. 
 
 
Fig. 3.6.4 Fractionated cell lysates ob-
tained after transfection with YFP-
TbMORN1(146-329). 
Procyclic Trypanosomes expressing YFP-
TbMORN1(146-329) were treated with 
detergent and cytoplasmic and membrane-
associated proteins were separated by cen-
trifugation. Equal fractions of input (I), so-
luble supernatant (SN) and insoluble pellet 
(P) were analyzed by SDS-PAGE and West-
ern blotting. Immunoblots were treated with 
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α-GFP antibodies. The 47kDa truncated 
protein was observed. Lanes contain a 1% 
fraction of each sample. 
 
 
3.7 Basepair exchange 
At the beginning of the project I had been using Bgl2 digested fragments which were 
ligated into BamH1 cut vectors. By this combination the digested fragment can be 
inserted in both orientations. To avoid insertion in wrong orientation and to increase 
cloning efficiency I wanted to get rid of the internal EcoR1 restriction site. Thus this 
construct carried a basepair exchange at base 1035 from TTC>TTT to abolish the 
EcoR1 site. There is little known about codon usage in Trypanosomes but data from 
Alonso et al. suggests that this basepair might be okay (Alonso et al., 1992). 
By immunofluorescence microscopy it was shown that the construct was expressed 
and targeted correctly to the bilobe as it was shown by colocaliaztion with TbLRRP1 
(Fig.3.7.1 A and B). 
Western blotting supports the idea that the base pair exchanged protein targeted to 
the cytoskeleton as a stronger signal from this fraction was observed (Fig.3.7.2). 
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Fig. 3.7.1 Localization of base pair exchanged full length TbMORN1. 
(A) Procyclic ells were fixed with PFA (A) or extracted and fixed with PFA (B) and 
stained with α-GFP antibodies. The YFP - tagged protein was present at the bilobe 
(arrows) as shown by colocalization with LRRP1. Nuclear and kinetoplast DNA 
were visualized with DAPI. Bars, 5µm. 
 
 
Fig. 3.7.2 Western blot analysis of frac-
tionated cell lysates obtained from base 
pair exchanged YFP-TbMORN1 trans-
fected cells. 
Procyclic cells were treated with extraction 
buffer and fractions were separated by cen-
trifugation. The Input (I), supernatant (SN) 
and the pellet (P) samples represent cytop-
lasmic and cytoskeletal proteins. Analysis 
by SDS-PAGE and Western blotting 
showed a 67kDa large protein recognized by 
α-GFP antibodies. Lanes contain a 1% frac-
tion of each sample. 
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3.8 Transfection efficiency 
During the project I performed transient transfections which means that not all cells 
will express the tagged protein. Since I was worried that low numbers of transfected 
cells could have an influence on the strength of localization I evaluated transfection 
efficiencies (TE) (Table 3.8-1.). Therefore I counted transfected and untransfected 
cells in 5 separate fields of view. I calculated the efficiency of single transfections 
and the mean TE. I observed that the TE of a single transfection varied between 3-
23% but that low TE did not reflect the paucity of localization. Some constructs with 
low TE did localize properly and others did not. Interestingly, the highest TE was 
counted for TbMORN1(1-358) and TbMORN1(1-350) where spears were also ob-
served. Further I was interested if the cell concentration at the time of transfection 
played a role for TE. I therefore plotted cell concentration and TE values (Fig. 3.8.1). 
No obvious correlation between TE and concentration was observed. There is in gen-
eral though a tendency for higher TEs at lower cell concentrations and lower TEs 
when the cell culture was denser. I think that this reflects that cells in mid log phase, 
10
6
 cell/ml, were easier to transfect than cells that were already in stationary phase, 
10
7
 cells/ml, and therefore take up DNA less efficiently. 
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TbMORN1 14 58 0,241 2 0,182 
 19 155 0,123   
TbMORN1(72-358) 15 110 0,136 2 0,124 
 17 153 0,111   
TbMORN1(146-358) 21 133 0,158 2 0,157 
 12 77 0,156   
TbMORN1(215-358) 24 198 0,121 2 0,097 
 8 111 0,072   
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TbMORN1(284-358) 11 106 0,104 2 0,157 
 28 133 0,211   
TbMORN1(330-358) 6 175 0,034 1  
TbMORN1(1-353) 9 136 0,066 1  
TbMORN1(1-350) 30 131 0,229 2 0,213 
 23 117 0,197   
TbMORN1(1-343) 5 48 0,104 2 0,088 
 11 154 0,071   
TbMORN1(1-336) 8 95 0,084 2 0,077 
 12 174 0,069   
TbMORN1(1-329) 8 107 0,075 2 0,106 
 15 109 0,138   
TbMORN1(1-320) 10 166 0,060 2 0,075 
 9 101 0,089   
TbMORN1(1-312) 17 159 0,107 2 0,124 
 17 120 0,142   
TbMORN1(1-260) 17 165 0,103 1  
TbMORN1(1-145) 12 142 0,085 2 0,131 
 18 101 0,178   
TbMORN1(146-343) 6 61 0,098 1  
TbMORN1(146-329) 9 89 0,101 1  
Table 3.8-1 Transfection efficiency. 
For each transient transfection the cells in 5 fields of view were counted. The trans-
fection efficiency of a single transfection was defined as transfected cells relative to 
untransfected ones. Mean is the mean transfection efficiency where multiple datasets 
were available. 
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Fig. 3.8.1 Transfection efficiency. 
Transfection efficiency was plotted against the culture concentration at the time of 
transfection. 
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4 Discussion 
My project had two main aims: screening the MORN-repeat proteins for bilobe local-
ization, and determining the targeting sequence of TbMORN1. These two projects 
will be considered in turn. 
4.1 The MORN-repeat protein family 
The aim of this project was to screen the MORN-repeat family proteins for possible 
bilobe localization. Therefore YFP-tagged fusion proteins were transiently expressed 
in Trypanosomes. All recombinant proteins expressed showed cytoplasmic α-GFP 
labelling in PFA- and MeOH-fixed cells. This uniform whole cell staining suggests a 
pool of YFP-tagged proteins present in the cytosol. Interestingly for protein 10 strong 
nuclear labelling in PFA-fixed cell was observed. This was surprising since protein 
10 does not have a nuclear localization signal. More specific localizations of fusion 
proteins were observed in detergent-extracted cytoskeletons (Table 4.1-1and 
Fig.4.1.1).  
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1 Tb927.8.3780 cyt. cyt. flagellum yes axoneme 
2 Tb927.3.2430 cyt. cyt. - no cyt. 
3 Tb927.7.3310 cyt. cyt. flagellum no axoneme 
4 Tb927.3.2890 cyt. cyt. flagellum yes axoneme 
5 Tb927.10.6230 - - - - - 
6 Tb927.10.14570 cyt. cyt. flagellum yes axoneme 
7 Tb927.7.6910 cyt. cyt. flagellum yes axoneme 
8 Tb927.10.10350 cyt. cyt. BB yes BB 
9 Tb11.02.5030 cyt. cyt. flagellum no axoneme 
10 Tb927.2.5040 cyt. 
nuc. 
- flagellum yes axoneme 
11 Tb11.01.1460 cyt. - BB yes BB 
12 Tb927.5.3880 cyt. - - yes cyt. 
  109 
mito. mito. 
13 Tb927.7.3400 cyt. - flagellum yes PFR 
14 Tb927.1.1910 - - - - - 
15 Tb927.3.4270 cyt. cyt. - yes cyt. 
16 Tb927.1.740 cyt. 
BB? 
- - no cyt. 
BB? 
17 Tb927.7.530 - - - - - 
Table 4.1-1 Summary of MORN-repeat proteins and their localizations 
cyt.: cytosolic; nuc.: nuclear; mito.: mitochondrial; BB: basal body 
 
Of the 17 screened proteins a total of 7, namely Proteins 1,3,4,6,7,9 and 10, localized 
to the axoneme. The flagellum is a highly complex organelle, essential for motility, 
has a role in cell morphogenesis and is crucial for cell polarity and division. The 
axoneme and the PFR form the flagellum of T.brucei. The axoneme ring structure of 
nine outer doublet microtubules and central pair of single microtubules is highly con-
served amongst eukaryotes. This part of the flagellum also contains conserved ele-
ments such as radial spokes, dynein arms and nexin links (Hammarton et al., 2007a). 
Furthermore the flagellum is supported by all kinds of molecular motor proteins 
through a highly active intra-flagellar transport. Due to this component variety it is 
possible that selected proteins might be interacting with one of these elements. The 
kinesin motor domain-containing Protein 6 is especially likely to be involved in flag-
ellar transport. 
Protein 13 colocalizes with the PFRA staining therefore I suggest that this protein 
could be part of the PFR. Three distinct zones- proximal, intermediate and distal di-
vide the PFR. The PFR is linked to the axoneme by robust filaments. The two major 
proteins are PFR1 and PFR2 (Gadelha et al., 2004) but its complete composition is 
still unknown. Therefore Protein 13 might be a structural component within the PFR. 
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Fig. 4.1.1 Summary of MORN-repeat protein family localization. 
7 proteins localized to the axoneme, 1 to the PFR, 2 were present at the basal body 
and 4 were found in the cytosol. 
The main MTOC in Trypanosomes is the basal body which is responsible for dupli-
cation and segregation of organelles. Furthermore the basal body is the nucleation 
site for the new flagellum. Our results show that two Proteins- 8 and 11 localize to 
both the mature and the pro-basal body. Due to their localization these proteins might 
be involved in segregation of the kinetoplast or assembly of the new axoneme. Pro-
tein 8 further has a predicted kinase domain which might also implement a regulatory 
function perhaps a role in cell cycle. 
Protein 2, 15 and 16 were considered as cytosolic proteins and Protein 16 might addi-
tionally be present on the basal body. Protein 2 has a predicted VPS9 domain which 
is a Rab5 GEF. It is therefore possible that this protein might play an important regu-
latory function by activating small GTPases. 
Interestingly, a meshed labelling pattern across the whole cell body was observed for 
Protein 12. This might be “mitochondrial” labelling although the analysis by Mito-
prot II shows a mitochondrial targeting chance of 0,038 and does not predict a cleav-
age site. I first also considered endoplasmatic reticulum localization but the typical 
ring around the nucleus was not observed. In Trypanosomes there are hardly any pro-
  111 
teins known which are exported to the mitochondrium it is therefore conceivable that 
Protein 12 is one of these or interacts with one of these components. 
Unfortunately, I encountered trouble cloning two constructs- Protein 14 where no 
positive clones were obtained and Protein 17 which is a huge protein and showed 
several deletions after sequencing. For these two constructs I suggest recloning by 
endogenous replacement. This method means cloning of the 5‟ untranslated region 
and the first approximately 500 bp of the ORF into a special vector which allows 
replacement of the endogenous gene by the YFP- flanked cassette through double 
crossover of homologous recombination. This method should lead to positive clones 
and abolish deletions. Owing to time limits this step could not be carried out. 
For Protein 5 I could not observe expression after transient transfection. Despite re-
peated attempts, it was not possible to generate a stably transfected cell line. I there-
fore consider that this tagged protein might be toxic for the cells. One possible ex-
periment to solve this problem could be to put the YFP tag at the N-terminus instead 
of the C-terminus or try a different, smaller tag like the Ty1 epitope for example. If 
over expression is the problem then endogenous replacement might be an option too. 
This would allow normal expression levels. 
Western blot of total cell lysates confirmed the expression of 9/14 proteins 
(1,4,6,7,8,10,11,13,15). Unfortunately for 5 proteins (2,3,12,16) no signal could be 
detected. I consider that the expression level might be too low in these cases. This is 
especially feasible for protein 12 and 16 where only a faint YFP signal was ever ob-
served. For better detection, cell lysates should be prepared at earlier time points af-
ter transfection and higher amounts of cells should be loaded on the gel. 
In summary 7 proteins localized to the axoneme, 1 to the PFR, 2 where found at the 
basal body, 3 where present in the cytosol and one might be mitochondrial. To study 
their possible functions RNAi experiments depleting the proteins would be the 
method of choice. In all cases the screened proteins were not targeted to the bilobe 
which implies that MORN-repeat sequences alone are not sufficient for bilobe local-
ization. This further suggests that a 3D motif in TbMORN1 might be the crucial fea-
ture. But 10/14 proteins were found on cytoskeletal structures which hints at a struc-
tural role of MORN-repeat proteins. 
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4.2 TbMORN1 truncation 
During this project the aim was to find the targeting sequence of TbMORN1 and 
define which MORN-repeats are essential and which are dispensable for targeting. 
Therefore N- and C-terminal truncation constructs were transiently expressed in pro-
cyclic Trypanosomes and screened by immunofluorescence microscopy for localiza-
tion redolent of the bilobe (Fig.4.2.1 A).  
 
Fig. 4.2.1 Summary of truncated constructs 
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Transient transfections with full-length YFP- tagged TbMORN1 showed that in in-
tact cells as well as in extracted cytoskeletons the fusion protein was found at the 
bilobe and colocalized with TbLRRP1 labelling. Additionally YFP-TbMORN1 
formed artefactual paracrystalline structures referred to as “spears”. Further I per-
formed immunoblotting of biochemically fractionated cell lysates obtained from 
YFP-TbMORN1 transfected cells. The YFP-tagged protein was present in all three 
fractions but a strong signal from the pellet fraction was observed. This indicates that 
YFP-TbMORN1 preferentially associates with the cytoskeleton. α-MORN1 antibod-
ies detected the endogenous TbMORN1 which was targeted exclusively to the cy-
toskeletal fraction. 
The N-terminal truncation, TbMORN1(72-358), had no effect on proper localization 
to the bilobe. Less protein was observed in the cytoskeletal fraction in western blots 
implying that more YFP-tagged protein stays in the cytosol. This coincided with the 
observation of faint cytosolic staining in PFΑ-fixed cells. A truncation construct 
missing the first 6 MORN-repeats, TbMORN1(146-358), was still targeted to the 
bilobe but was additionally found in the cytosol and at the basal bodies. This implies 
that amino acids 72-146 are necessary for localization exclusively to the bilobe. 
However on Western blot no signal for the cytoskeletal fraction was observed which 
remains an unresolved question so far. I suggest that the exposure time was not set 
long enough to detect fainter bands. The construct TbMORN1(215-358) also local-
ized to the cytosol, the basal body and the bilobe. The Western blot analysis revealed 
that some protein was targeted to the cytoskeleton. The construct containing amino 
acids 284-358 was no longer observed at the bilobe in intact cells, but in the cytosol 
and at the basal bodies. However extraction of cytoskeletons lead to the loss of basal 
body signal. Thus, amino acids 215-284 are necessary for targeting to the bilobe. 
This matches with the observation that for the cytoskeletal fraction only a very faint 
signal was detected. The last MORN-repeat, TbMORN1(330-358), still showed basal 
body labelling which suggests that amino acids 330-358 are sufficient for basal body 
localization. In Western blot analysis only signals from the input and the supernatant 
could be observed. The missing signal from the cytoskeleton could be due to the fact 
that the basal body signal might be too weak and that little amount of protein might 
not be detected. Combining the data from the N-terminal truncations there are 3 im-
portant domains that are: 1-72 for localization only to the bilobe, 215-284 for bilobe 
targeting and 330-358 for basal body localization. 
The C-terminal truncations complicated this picture. TbMORN1(1-353) localized 
correctly to the bilobe but also showed nuclear labelling. It is known that TbMORN1 
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does not target to the nucleus and therefore I suggest that it is due to antibody which 
is nonspecifically bound. Furthermore no spears could be observed and the signal 
from the bilobe was less strong than for other constructs which might indicate that 
this protein was expressed at a lower level. This low level expression might also ex-
plain why no signal could be recognized on Western blot. However the construct 
missing the last 8 amino acids, TbMORN1(1-350), did localize properly but was also 
present in the cytosol and at the basal body. Interestingly the formation of spears was 
observed in 53% of transfected cells. Blotting of fractionated cell lysates backed up 
the idea that the YFP-tagged protein was mainly present in the cytosol and little was 
targeted to the cytoskeleton. TbMORN1(1-343) was observed in the cytosol, at the 
basal bodies and a structure next the kinetoplast in intact cells. After detergent ex-
traction however no signal from any structure could be detected. TbMORN1(1-336) 
showed the same labelling pattern in intact cells but localized to the bilobe even after 
detergent extraction. Oddly for construct TbMORN1(1-329) no signal could be ob-
served in detergent extracted cytoskeletons. TbMORN1(1-320) in contrast did again 
localize to the bilobe even after treatment with extraction buffer. On Western blot all 
these constructs showed a strong band in the supernatant and a faint signal in the 
pellet fraction. TbMORN1(1-312) showed the common labelling pattern of cytosolic, 
basal body and bilobe structure in the intact cells. After extraction the protein was 
still found at the bilobe. Western blots also displayed the pattern that most of the 
signal was present in the cytoplasmic fraction and little was found in the pellet. The 
construct containing amino acid 1-260, TbMORN1(1-260) was also found in the 
cytosol, at the basal body and at the bilobed structure, but the signal from these cy-
toskeletal structures was lost after extraction. Only MORN1(1-145) showed exclu-
sively cytosolic staining and no basal body signal. Western blots back up this idea 
since no band for the cytoskeletal fraction was observed. In summary the importance 
of 3 domains were determined. Amino acids 350-353 seems to the necessary for tar-
geting exclusively to the bilobe all other proteins are additionally found in the cytosol 
and at the basal bodies. The domain 343-350 seems to be important for spear forma-
tion suggesting that the far C-terminus was needed to form paracrystalline artefacts. 
Furthermore amino acids 145-260 are indispensible for bilobe and basal body target-
ing. 
Further constructs truncated from both ends were created; TbMORN1(146-343) 
which we would expect to localize to the cytosol, the basal bodies and the bilobe as it 
was observed for TbMORN1(146-358) and TbMORN1(1-343). Interestingly the 
YFP-tagged protein was only observed to be cytosolic in PFΑ-fixed cells. This im-
plies that amino acids 145-260 are not sufficient for bilobe or basal body targeting. 
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The same behaviour was observed for construct TbMORN1(146-329). This suggests 
that truncated proteins might be too short and that the localization was achieved 
through structural features of TbMORN1. This indicates that the structure might play 
an important role in targeting. 
Furthermore I was worried that low numbers of transfected cells could have an influ-
ence on the strength of localization. But as evaluation of TEs showed the variation of 
TEs was little and there was no connection between low TE value and abundant lo-
calization observed. 
For nearly all truncation constructs basal body labelling in intact cells was observed. 
Interestingly, the signal from the basal body was lost after extraction which might 
indicate a weak, reversible association. I think that this labelling might reflect traf-
ficking of TbMORN1 through the basal body and that truncated versions are possibly 
delayed at the basal body. Something similar was noted in recent experiments on the 
small G protein Rab-like 5 in Trypanosomes. RABL5 exhibited cytosolic, basal body 
and flagellum staining. Interestingly, in IFT RNAi cells this protein was only found 
at the basal body (Adhiambo et al., 2008). This indicates that the basal body might 
play an important role as a staging post in cytosolic protein trafficking. 
During the project I observed that the constructs exhibited different strength of 
bilobe localization. Some showed a good bilobe signal whereas other displayed faint 
bilobe signalling. It is possible that truncated constructs alone would not localizae to 
the bilobe but that truncated proteins can bind to endogenous TbMORN1 and there-
fore target properly. 
Surprisingly, the spear formation was only observed for TbMORN1 and 
TbMORN1(1-350). All other N- or C-terminal truncations did not show these arte-
factual structures. This implements that the far C-terminus is needed for spear forma-
tion and self- association. 
Combining data from all truncations I found that 5 domains are important. Amino 
acid 1-72 and 350-353 are required for targeting exclusively to the bilobe. The do-
main 343-350 was found to be important for the formation of spears. Amino acid 
215-312 are necessary for bilobe targeting. For targeting to the basal body, the last 
MORN-repeat, was sufficient. 
I also observed a strange pattern of localization and mis-localization to the bilobe in 
C-terminal truncations, TbMORN1(1-350)- TbMORN1(1-260). I suggest that this 
unusual observation could be explained by hydrophobicity. In figure 4.2.2 I plotted 
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TbMORN1 sequence by Kyte & Doolite approximation to delineate the hydrophobic 
character of the protein (Fig.4.2.2). Regions with values above 0 are hydrophobic in 
character and negative values represent hydrophilic residues. Interestingly, 
TbMORN1 shows 3 hydrophobic loops from amino acid 300 to 358. When we intro-
duce the constructs we can see that when we cut after a hydrophobic loop which is 
true for TbMORN1(1-350), TbMORN1(1-336) and TbMORN1(1-320), the truncated 
protein did properly localize to the bilobe. In contrast when we cut within one of 
these loops, TbMORN1(1-343) and TbMORN1(1-329) the targeting to the bilobe is 
inhibited. I therefore suggest that the hydrophobicity of the far C-terminus has an 
important role in targeting TbMORN1. 
 
Fig. 4.2.2 Hydrophobicity plot of TbMORN1. 
This plot shows the distribution of polar and apolar residues along the protein. There-
fore the sequence is scanned with a moving window of fixed size (= 9). At each 
amino acid the mean hydrophobic index within the window is calculated and plotted. 
Hydrophobic regions have values above 0. Hydrophilic characters have negative val-
ues. 
Recently it was shown that the MORN1 protein in T. gondii has a predicted palmi-
tolyation site and that mutation of this site leads to localization to the centrocone 
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instead of to the basal end (Lorestani et al., 2010). Surprisingly, TbMORN1 has a 
predicted palmitolyation site too. This site at Cysteine 17 is predicted even under the 
most stringent conditions. We know from studies on palmitoylation that for many 
proteins the palmitoylation is essential for stable membrane association (Salaun et 
al., 2010). 
Only TbMORN1(1-358), TbMORN1(72-358) and TbMORN1(1-353) localized ex-
clusively to the bilobe which we consider as a strong, stable association (Fig.4.2.1. 
B). All others that localized to the bilobe also showed basal body labelling therefore 
showed impaired targeting. Basal body labelling is only observed in intact cells and 
not in extracted cytoskeletons. This observation might be explained by a weak asso-
ciation at the basal body. Furthermore we sometimes observed bilobe labelling in 
PFA-fixed cells but not necessarily after extraction (Fig.4.2.1. B, class 2,3). This 
stable and weak association might be explained by the hydrophobicity plot. Some-
times we only observed localization to the basal body (Fig.4.2.1. B, class 4) which 
we consider as the first stage of targeting. 
Over all I propose the following model - I think that TbMORN1 traffics to the bilobe 
via the basal body since I observed basal body labelling for most of the truncated 
constructs (Fig.4.2.3). This coincides with the observation that by biochemical frac-
tionation more protein comes down in the supernatant. Data from the hydrophobcity 
plot further suggests that TbMORN1 might be reversibly bound to the plasma mem-
brane by its hydrophobic loops at the C-terminus. The final stable association might 
then be performed by palmitoylation linkage at Cysteine 17. 
 
Fig. 4.2.3 Model for TbMORN1 targeting. 
(A) New molecules of TbMORN1 dock at basal body. Weak association. (B) Mole-
cules traffic up to the bilobe (maybe on the microtubular quartet). At bilobe they oli-
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gomerize forming a strong and stable association. Palmitoylation occcurs to achieve 
a strong and stable association with the plasma membrane. 
To support the conclusions from TbMORN1(145-358) further truncation constructs, 
shorter than amino acid 145 need to be done. Additionally I suggest preparing stable 
cell lines for TbMORN1(1-145) and TbMORN1(284-358) to check for the lack of 
localization to the bilobe. To confirm basal body localization electron microscopy on 
truncated proteins could be performed. To further support conclusions from the hy-
drophobicity plot a construct TbMORN1(1-346) could be generated. Finally a palmi-
toylation assay should be carried out to check if the predicted site shows this post-
translational modification. 
From the MORN-repeat protein family we can conclude that the MORN-repeat se-
quence alone does not lead to targeting to the bilobe. 10/14 MORN-repeat proteins 
were found on cytoskeletal structures which suggests a structural role. However fur-
ther studies investigating the possible function of MORN-repeats still need to be 
done. Something in TbMORN1 is targeting the protein to the bilobe. It is possible 
that the targeting is achieved through a sequence that is not part of the MORN-repeat 
consensus sequence. From my data I suggest that a 3D motif is the crucial factor for 
targeting TbMORN1. 
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5 List of Abbreviations 
BSA  bovine serum albumin 
CIP  calf intestinal phosphatase 
DAPI  4‟2-diamidin-2-phenylindol 
E.  Escherichia 
ERES  endoplasmic reticulum export site 
EtOH  ethanol 
FAZ  flagellum attachment zone 
FP  flagellar pocket 
GEF  guanidine exchange factor 
GFP  green fluorescent protein 
HiFi  high fidelity 
I  input 
IFT  intra-flagellar transport 
MeOH  methanol 
min  minute(s) 
MT  microtubule 
MTOC microtubular organizing center 
MORN membrane occupation and recognition nexus 
ORF  open reading frame 
PCR  polymerase chain reaction 
PFA  paraformaldehyde 
PFR  paraflagellar rod 
PLK  polo-like kinase 
PIPK  phosphatidylinositolphosphate kinase 
RNAi  RNA interference 
SDS  sodium dodecyl sulfate 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SN  supernatant 
TE  transfection efficiency 
T.  Trypanosoma 
VSG  variant surface glycoprotein 
Xtr  detergent - extracted 
YFP  yellow fluorescent protein 
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9 APPENDIX 
List of antibodies 
 
List of constructs 
Name Protein PCR primers 
1. Tb927.8.3780 Tb927.8.3780 Tb927.8.3780_Bam_F 
Tb927.8.3780_Eco_R 
2. Tb927.3.2430 Tb927.3.2430 Tb927.3.2430_Bam_F 
Tb927.3.2430_Bam_R 
3. Tb927.7.3310 Tb927.7.3310 Tb927.7.3310_Bam_F 
Tb927.7.3310_Eco_R 
4. Tb927.3.2890 Tb927.3.2890 Tb927.3.2890_Hind_F 
Tb927.3.2890_Nhe_R 
5. Tb10.70.0600 Tb927.10.6230 Tb10.70.0600_Nhe_F 
Tb10.70.0600_Nhe_R 
6. Tb10.61.2100 Tb927.10.14570 Tb10.61.2100_Hind_F 
Tb10.61.2100_Nhe_R 
7. Tb927.7.6910 Tb927.7.6910 Tb927.7.6910_Hind_F 
Tb927.7.6910_Nhe_R 
8. Tb10.406.0580 Tb927.10.10350 Tb10.406.0580_Hind_F 
 Name Dilution Company/Reference 
Primary 
Antibodies 
rabbit-α-GFP 1: 5000 Seedorf et al., 1999 
 mouse-α-PFRA 1: 10000 Kohl et al., 1999 
 rat YL1/2 1: 1000 Abcam  
 mouse-α-BB4A 1:10 Woods et al., 1989 
 mouse-α-Cen2 1.25 Warren lab, unpub-
lished to date 
 mouse-α-LRRP1 1:5000 Zhou et al., 2010 
Secondary 
Antibodies 
goat-α-rabbit 488 1: 3000 Molecular Probes 
 goat-α-rabbit 568 1:3000 Molecular Probes 
 goat-α-mouse IgG 568 1: 3000 Molecular Probes 
 goat-α-mouse IgM 568 1:3000 Molecular Probes 
 goat-α-rat 555 1: 3000 Molecular Probes 
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Tb10.406.0580_Nhe_R 
9. Tb11.02.5030 Tb11.02.5030 Tb11.02.5030_Bam_F 
Tb11.02.5030_Eco_R 
10. Tb927.2.5040 Tb927.2.5040 Tb927.2.5040_Bam_F 
Tb927.2.5040_Eco_R 
11. Tb11.01.1460 Tb11.01.1460 Tb11.01.1460_Bam_F 
Tb11.01.1460_Eco_R 
12. Tb927.5.3880 Tb927.5.3880 Tb927.5.3880_Hind_F 
Tb927.5.3880_Nhe_R 
13. Tb927.7.3400 Tb927.7.3400 Tb927.7.3400_Hind_F 
Tb927.7.3400_Nhe_R 
14. Tb927.1.1910 Tb927.1.1910 Tb927.1.1910_Bcl_F 
Tb927.1.1910_Eco_R 
15. Tb927.3.4270 Tb927.3.4270 Tb927.3.4270_Hind_F 
Tb927.3.4270_Nhe_R 
16. Tb927.1.740 Tb927.1.740 Tb927.1.740_Bam_F 
Tb927.1.740_Eco_R 
17. Tb927.7.530 Tb927.7.530 Tb927.7.530_Hind_F 
Tb927.7.530_Nhe_R 
   
TbMORN1(1-358) TbMORN1(1-358) MORN1-5' Blg2 
MORN1-3'Bgl2 
E, TbMORN1(72-358) TbMORN1(72-358) MORN1(72-358)_Bgl2_F 
MORN1-3'Bgl2 
2, TbMORN1(146-358) TbMORN1(146-358) MORN1-IntBGL2-F 
MORN1-3'Bgl2 
A, TbMORN1(215-358) TbMORN1(215-358) 6xMORN1-IntBGL2-F 
MORN1-3'Bgl2 
B, TbMORN1(284-358) TbMORN1(284-358) 3xMORN1-IntBGL2-F 
MORN1-3'Bgl2 
L, TbMORN1(330-358)  TbMORN1(330-358) MORN(330)_BamH_F 
MORN1-3'Bgl2 
K, TbMORN1(1-353)  TbMORN1(1-353) MORN1-5' Blg2 
MORN(354)_Mut_Eco 
I, TbMORN1(1-350)  TbMORN1(1-350) MORN1-5' Blg2 
MORN(350)_Mut_Eco_R 
C, TbMORN1(1-343) TbMORN1(1-343) MORN1-5' Blg2 
cutCterMORN1-IntBgl2-
R 
H, TbMORN1(1-336) TbMORN1(1-336) MORN1-5' Blg2 
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MORN1(1-336)_Eco-R 
F, TbMORN1(1-329)  TbMORN1(1-329) MORN1-5' Blg2 
MORN1(1-329)_Eco_R 
P, TbMORN1(1-320) TbMORN1(1-320) MORN1-5' Blg2 
MORN(320)_Eco_R 
O, TbMORN1(1-312) TbMORN1(1-312) MORN1-5' Blg2 
MORN(312)_Eco_R 
Q, TbMORN1(1-260) TbMORN1(1-260) MORN1-5' Blg2 
MORN1(260)_Eco-R 
1, TbMORN1(1-145) TbMORN1(1-145) MORN1-5' Blg2 
1.MORN1sequence 
D, TbMORN1(146-343) TbMORN1(146-343) MORN1-IntBGL2-F 
cutCterMORN1-IntBgl2-
R 
G, TbMORN1(146-329) TbMORN1(146-329) MORN1-IntBGL2-F 
MORN1(1-329)_Eco_R 
 
List of Primers 
Name F
/
R 
Site Sequence 
Tb927.8.3780_Bam_F 
Tb927.8.3780_Eco_R 
F 
R 
BamHI 
EcoRI 
cggggatccATGCCACCCAAAAA-
GAAGGTG 
cgggaattcC-
TAACCCTCTTTTTCATCCTTC 
Tb927.3.2430_Bam_F 
Tb927.3.2430_Bam_R 
F 
R 
BamHI 
BamHI 
cggggatccAT-
GAAACGATGCAACAGTGAG 
cggggatccTTATAAAATA-
GATGCAATAAA 
Tb927.7.3310_Bam_F 
Tb927.7.3310_Eco_R 
F 
R 
BamHI 
EcoRI 
cggggatccATGTGTA-
TATGCATGTATGCC 
cgggaattcCTACAGAGAATCCTCTA-
CAAT 
Tb927.3.2890_Hind_F 
Tb927.3.2890_Nhe_R 
F 
R 
HindIII 
NheI 
cggaagcttATGTCGAAGCAAAA-
GAATGTG 
cgggctag-
cATCGGTCCACGTCATGCCGTC 
Tb10.70.0600_Nhe_F 
Tb10.70.0600_Nhe_R 
F 
R 
NheI 
NheI 
cgggctagcATGTTAACTGTAACGGAG-
GAT 
  132
cgggctagcGGCAGCGTAAATACCGTTTT
T 
Tb10.61.2100_Hind_F 
Tb10.61.2100_Nhe_R 
F 
R 
HindIII 
NheI 
cggaagcttATGGAGAATTCCAGTTCGTT 
cgggctagcCTCTACATC-
CAAGCCCCATCC 
Tb927.7.6910_Hind_F 
Tb927.7.6910_Nhe_R 
F 
R 
HindIII 
NheI 
cggaagcttATGTCGGGAAGTGACGCA-
GAA 
cgggctagcTTCCTTGGTCGCCACAG-
CAGC 
Tb10.406.0580_Hind_F 
Tb10.406.0580_Nhe_R 
F 
R 
HindIII 
NheI 
cggaagcttATGAGTACACAA-
GAATCTCAT 
cgggctagcAAACGTAA-
GAAATGGATGTTT 
Tb11.02.5030_Bam_F 
Tb11.02.5030_Eco_R 
F 
R 
BamHI 
EcoRI 
gccggatccATGACAACGAAGGAAG-
CAGTG 
ccggaattcTCACACCCCGTCATGAGAGG 
Tb927.2.5040_Bam_F 
Tb927.2.5040_Eco_R 
F 
R 
BamHI 
EcoRI 
gccggatccATGCAGAGGGACGCTGACAG 
ggcgaattcCTATAAAC-
TAACCTCCGCAAGC 
Tb11.01.1460_Bam_F 
Tb11.01.1460_Eco_R 
F 
R 
BamHI 
EcoRI 
ggcggatccATGCTAGACAAAGTTGTAGG 
ggcgaattcTCACCGGACAGTAAGAG-
GAAAG 
Tb927.5.3880_Hind_F 
Tb927.5.3880_Nhe_R 
F 
R 
HindIII 
NheI 
cggaagcttATGGTCGGCAGCGCATCGCG
G 
ggcgctagcTCTCCCTCCCGTATCCGCAA 
Tb927.7.3400_Hind_F 
Tb927.7.3400_Nhe_R 
F 
R 
HindIII 
NheI 
cggaagcttATGGCTTTGGGATCAG-
GAATC 
ggcgctagcTGTTGGTGCATCCGCCATAC 
Tb927.1.1910_Bcl_F 
Tb927.1.1910_Eco_R 
F 
R 
BclI 
EcoRI 
cggtgatcaATGTTACCATCCTCTCAGGAC 
ccggaattcTCAAACATCTCCGGTATCAG 
Tb927.3.4270_Hind_F 
Tb927.3.4270_Nhe_R 
F 
R 
HindIII 
NheI 
cggaagcttATGGGGCATCCGAG-
CGACAGC 
ggcgctagcCATGAGGCTGGCAA-
GATCCTG 
Tb927.1.740_Bam_F 
Tb927.1.740_Eco_R 
F 
R 
BamHI 
EcoRI 
gccggatc-
cATGTTTGTGCGCCGGTTGGTG 
ggcgaattcTTATCCCTTTGAGGTAAAGG 
Tb927.7.530_Hind_F 
Tb927.7.530_Nhe_R 
F 
R 
HindIII 
NheI 
cggaagcttATGCCCGATAACAATAACAA 
ggcgctagcACTTTCACTACTAGCTGGC 
Internal sequencing 
primers 
   
  133 
2 Tb927.3.2430 internal 
primer F 
F  GGTTCCATGACACTGGCACGC 
2Internal-reverse R  CTCACTACTAAGGTCCACCAGC 
5Int-Fbeginn F  GGCAACTCCTGTGGCGAGGGCGTCGC
TACTCGG 
5TbInternal-F F  GGGAAGAAGGAGGGTCTTGGTGT 
6 Tb10.61.2100 internal 
primer F 
F  GGGCGTTGCAGGTGATCAGC 
7 Tb927.7.6910 internal 
primer F 
F  CGTCGTCACGGTGTCGGCGTG 
8Tb10.406.0580 inter-
nal primer F 
F  GCGTATGCTCGGAGAGGGTC 
12Int-F F  CACTGCCCCAGTTCTCCTTCTCGCC 
Site-directed mutagene-
sis 
   
3SDM-Fnew F  CTGTACATACAAGGAAGGAACAAAA
AAAAAAGCATCAGCACAACCTGCAG 
3SDM-Rnew R  CTGCAGGTTGTGCTGATGCTTTTTTTT
TTGTTCCTTCCTTGTATGTACAG 
Sequencing primers    
EGFP-C1-F F  GAAGCGCGATCACATGGTC 
Primer YFP reverse R  GCGGTTCACCAGGGTGTCGCCCTCG 
MORN1-5' Blg2 F Bgl2 gaagatctATATACTCTGGTGAGATA-
GAAAATGG 
MORN1-3'Bgl2 R Bgl2 gaagatctATAATCCGGATTGCTGAGAT-
CACAG 
MORN1(72-
358)_Bgl2_F 
F Bgl2 cggagatctTATACTGGAGAATGGAG-
TATGGGCC 
MORN1-IntBGL2-F F Bgl2 cggagatctTACGACGG-
CGAATGGAACGAAG 
6xMORN1-IntBGL2-F 
 
F Bgl2 cgga-
gatctTACGAGGGCTACTGGCACCTCG 
3xMORN1-IntBGL2-F 
 
F Bgl2 cgga-
gatctTACGAGGGTGAGTGGGCTGAGG 
MORN(330)_BamH_F 
 
F BamH1 cggggatccGTACATTGGAACCTGGAAG-
GATG 
MORN(354)_Mut_Eco R EcoR1 gccgaattcCTGAGATCACAGTTCTCA-
GACAATCGAAATTCACCC 
MORN(350)_Mut_Eco
_R 
R EcoR1 ggcgaattcGTTCTCAGACAATCGAAATT-
CACC 
cutCterMORN1- R Bgl2 ccgagatctACCCTGACCCACAAT-
  134
IntBgl2-R GACCCCATCC 
MORN1(1-336)_Eco-R R EcoR1 ggcgaatt-
cATCCTTCCAGGTTCCAATGTAC 
MORN1(1-329)_Eco_R R EcoR1 ggcgaattcCATGGAGCCGTCCTTGA-
GAATTATCTTCCC 
MORN(320)_Eco_R R EcoR1 ggcgaattcCCCGGGGCCATCCTTCTTTCC
ATGCG 
MORN(312)_Eco_R R EcoR1 ggcgaattcCGCAAAT-
GATCCCTCATAGCTGG 
MORN1(260)_Eco-R R EcoR1 ggcgaattcATGTGTCCCCATTGCTATAGC 
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